{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:39:31Z","timestamp":1790959171351,"version":"4.1.0"},"reference-count":347,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T00:00:00Z","timestamp":1692403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T00:00:00Z","timestamp":1692403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Sichuan Science and Technology Program","award":["2022YFS0620"],"award-info":[{"award-number":["2022YFS0620"]}]},{"name":"Sichuan Science and Technology Program","award":["2022YFS0620"],"award-info":[{"award-number":["2022YFS0620"]}]},{"name":"Sichuan Science and Technology Program","award":["2022YFS0620"],"award-info":[{"award-number":["2022YFS0620"]}]},{"DOI":"10.13039\/501100014895","name":"Southwest Medical University","doi-asserted-by":"crossref","award":["2021ZKZD015"],"award-info":[{"award-number":["2021ZKZD015"]}],"id":[{"id":"10.13039\/501100014895","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100014895","name":"Southwest Medical University","doi-asserted-by":"crossref","award":["2021ZKZD018"],"award-info":[{"award-number":["2021ZKZD018"]}],"id":[{"id":"10.13039\/501100014895","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2020YFA0112700"],"award-info":[{"award-number":["2020YFA0112700"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Macao Science and Technology Development Fund of Macao SAR","award":["SKL-QRCM(MUST)-2020-2022 and MUST-SKL-2021-005"],"award-info":[{"award-number":["SKL-QRCM(MUST)-2020-2022 and MUST-SKL-2021-005"]}]},{"name":"Luzhou Science and Technology Project","award":["2022-SYF-73"],"award-info":[{"award-number":["2022-SYF-73"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Ophthalmic inflammatory diseases, including conjunctivitis, keratitis, uveitis, scleritis, and related conditions, pose considerable challenges to effective management and treatment. This review article investigates the potential of advanced nanomaterials in revolutionizing ocular anti-inflammatory drug interventions. By conducting an exhaustive analysis of recent advancements and assessing the potential benefits and limitations, this review aims to identify promising avenues for future research and clinical applications. The review commences with a detailed exploration of various nanomaterial categories, such as liposomes, dendrimers, nanoparticles (NPs), and hydrogels, emphasizing their unique properties and capabilities for accurate drug delivery. Subsequently, we explore the etiology and pathophysiology of ophthalmic inflammatory disorders, highlighting the urgent necessity for innovative therapeutic strategies and examining recent preclinical and clinical investigations employing nanomaterial-based drug delivery systems. We discuss the advantages of these cutting-edge systems, such as biocompatibility, bioavailability, controlled release, and targeted delivery, alongside potential challenges, which encompass immunogenicity, toxicity, and regulatory hurdles. Furthermore, we emphasize the significance of interdisciplinary collaborations among material scientists, pharmacologists, and clinicians in expediting the translation of these breakthroughs from laboratory environments to clinical practice. In summary, this review accentuates the remarkable potential of advanced nanomaterials in redefining ocular anti-inflammatory drug therapy. We fervently support continued research and development in this rapidly evolving field to overcome existing barriers and improve patient outcomes for ophthalmic inflammatory disorders.<\/jats:p><jats:p><jats:bold>Graphical Abstract<\/jats:bold><\/jats:p>","DOI":"10.1186\/s12951-023-01974-4","type":"journal-article","created":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T15:01:44Z","timestamp":1692457304000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":81,"title":["Next-generation nanomaterials: advancing ocular anti-inflammatory drug therapy"],"prefix":"10.1186","volume":"21","author":[{"given":"Jing","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyu","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalian","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junguo","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anguo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,19]]},"reference":[{"key":"1974_CR1","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/398076","volume":"2015","author":"V Huerva","year":"2015","unstructured":"Huerva V, Ascaso FJ, Grzybowski A. Ocular inflammation. Mediators Inflamm. 2015;2015: 398076.","journal-title":"Mediators Inflamm"},{"key":"1974_CR2","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2023.109417","volume":"229","author":"J Shan","year":"2023","unstructured":"Shan J, Li L, Du L, Yang P. Association of TBX21 gene polymorphisms and acute anterior uveitis risk in a Chinese population: a case-control study. Exp Eye Res. 2023;229: 109417.","journal-title":"Exp Eye Res"},{"key":"1974_CR3","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ajo.2020.04.043","volume":"217","author":"TT Xu","year":"2020","unstructured":"Xu TT, Reynolds MM, Hodge DO, Smith WM. Epidemiology and clinical characteristics of episcleritis and scleritis in Olmsted County. Minnesota Am J Ophthalmol. 2020;217:317\u201324.","journal-title":"Minnesota Am J Ophthalmol"},{"issue":"2","key":"1974_CR4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/1756285611398702","volume":"4","author":"E Voss","year":"2011","unstructured":"Voss E, Raab P, Trebst C, Stangel M. Clinical approach to optic neuritis: pitfalls, red flags and differential diagnosis. Ther Adv Neurol Disord. 2011;4(2):123\u201334.","journal-title":"Ther Adv Neurol Disord"},{"issue":"3","key":"1974_CR5","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1007\/s13346-020-00843-z","volume":"11","author":"SA Gaballa","year":"2021","unstructured":"Gaballa SA, Kompella UB, Elgarhy O, Alqahtani AM, Pierscionek B, Alany RG, et al. Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives. Drug Deliv Transl Res. 2021;11(3):866\u201393.","journal-title":"Drug Deliv Transl Res"},{"issue":"3","key":"1974_CR6","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/ceo.13702","volume":"48","author":"AT Fung","year":"2020","unstructured":"Fung AT, Tran T, Lim LL, Samarawickrama C, Arnold J, Gillies M, et al. Local delivery of corticosteroids in clinical ophthalmology: A review. Clin Exp Ophthalmol. 2020;48(3):366\u2013401.","journal-title":"Clin Exp Ophthalmol"},{"issue":"1","key":"1974_CR7","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ophtha.2012.07.052","volume":"120","author":"AC Gregory 2nd","year":"2013","unstructured":"Gregory AC 2nd, Kempen JH, Daniel E, Ka\u00e7maz RO, Foster CS, Jabs DA, et al. Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the Systemic Immunosuppressive Therapy for Eye Diseases Study. Ophthalmology. 2013;120(1):186\u201392.","journal-title":"Ophthalmology"},{"issue":"108","key":"1974_CR8","first-page":"85","volume":"33","author":"J Hoffman","year":"2020","unstructured":"Hoffman J. Overview of antiviral medications used in ophthalmology. Community Eye Health. 2020;33(108):85\u20138.","journal-title":"Community Eye Health"},{"key":"1974_CR9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.colsurfb.2015.04.056","volume":"132","author":"NK Mehra","year":"2015","unstructured":"Mehra NK, Jain NK. Cancer targeting propensity of folate conjugated surface engineered multi-walled carbon nanotubes. Colloids Surf B Biointerfaces. 2015;132:17\u201326.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"9","key":"1974_CR10","doi-asserted-by":"crossref","first-page":"5257","DOI":"10.1021\/nl502275s","volume":"14","author":"A Rajala","year":"2014","unstructured":"Rajala A, Wang Y, Zhu Y, Ranjo-Bishop M, Ma JX, Mao C, et al. Nanoparticle-assisted targeted delivery of eye-specific genes to eyes significantly improves the vision of blind mice in vivo. Nano Lett. 2014;14(9):5257\u201363.","journal-title":"Nano Lett"},{"issue":"1","key":"1974_CR11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2174\/1574888X15666200210104449","volume":"16","author":"N Liu","year":"2021","unstructured":"Liu N, Wu Q, Liu Y, Li J, Ji P, Fu G. Application of nanomaterials in the treatment and diagnosis of ophthalmology diseases. Curr Stem Cell Res Ther. 2021;16(1):95\u2013103.","journal-title":"Curr Stem Cell Res Ther"},{"key":"1974_CR12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fcvm.2017.00087","volume":"4","author":"S Katsuki","year":"2017","unstructured":"Katsuki S, Matoba T, Koga JI, Nakano K, Egashira K. Anti-inflammatory nanomedicine for cardiovascular disease. Front Cardiovasc Med. 2017;4:87.","journal-title":"Front Cardiovasc Med"},{"issue":"4","key":"1974_CR13","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/1061186X.2017.1367006","volume":"26","author":"RR Wakaskar","year":"2018","unstructured":"Wakaskar RR. General overview of lipid-polymer hybrid nanoparticles, dendrimers, micelles, liposomes, spongosomes and cubosomes. J Drug Target. 2018;26(4):311\u20138.","journal-title":"J Drug Target"},{"issue":"1","key":"1974_CR14","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41467-020-20276-z","volume":"12","author":"VP Nguyen","year":"2021","unstructured":"Nguyen VP, Qian W, Li Y, Liu B, Aaberg M, Henry J, et al. Chain-like gold nanoparticle clusters for multimodal photoacoustic microscopy and optical coherence tomography enhanced molecular imaging. Nat Commun. 2021;12(1):34.","journal-title":"Nat Commun"},{"issue":"10","key":"1974_CR15","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1080\/02713683.2019.1660793","volume":"44","author":"S Sarwat","year":"2019","unstructured":"Sarwat S, Stapleton F, Willcox M, Roy M. Quantum dots in ophthalmology: a literature review. Curr Eye Res. 2019;44(10):1037\u201346.","journal-title":"Curr Eye Res"},{"key":"1974_CR16","doi-asserted-by":"crossref","first-page":"9763","DOI":"10.2147\/IJN.S225992","volume":"14","author":"Y Wang","year":"2019","unstructured":"Wang Y, Liu W, Yuan B, Yin X, Li Y, Li Z, et al. The application of methylprednisolone nanoscale zirconium-porphyrin metal-organic framework (mps-npmof) in the treatment of photoreceptor degeneration. Int J Nanomedicine. 2019;14:9763\u201376.","journal-title":"Int J Nanomedicine"},{"issue":"7638","key":"1974_CR17","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nature19831","volume":"541","author":"H Lin","year":"2017","unstructured":"Lin H, Ouyang H, Zhu J, Huang S, Liu Z, Chen S, et al. Corrigendum: Lens regeneration using endogenous stem cells with gain of visual function. Nature. 2017;541(7638):558.","journal-title":"Nature"},{"issue":"8","key":"1974_CR18","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1002\/jbm.a.36699","volume":"107","author":"I Cruz-Maya","year":"2019","unstructured":"Cruz-Maya I, Guarino V, Almaguer-Flores A, Alvarez-Perez MA, Varesano A, Vineis C. Highly polydisperse keratin rich nanofibers: Scaffold design and in vitro characterization. J Biomed Mater Res A. 2019;107(8):1803\u201313.","journal-title":"J Biomed Mater Res A"},{"issue":"1","key":"1974_CR19","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1080\/21655979.2020.1736240","volume":"11","author":"K Khalid","year":"2020","unstructured":"Khalid K, Tan X, Mohd Zaid HF, Tao Y, Lye Chew C, Chu DT, et al. Advanced in developmental organic and inorganic nanomaterial: a review. Bioengineered. 2020;11(1):328\u201355.","journal-title":"Bioengineered"},{"issue":"4","key":"1974_CR20","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.nano.2017.02.007","volume":"13","author":"MA Kamaleddin","year":"2017","unstructured":"Kamaleddin MA. Nano-ophthalmology: applications and considerations. Nanomedicine. 2017;13(4):1459\u201372.","journal-title":"Nanomedicine"},{"key":"1974_CR21","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.2147\/IJN.S239751","volume":"15","author":"J Wang","year":"2020","unstructured":"Wang J, Wu X, Shen P, Wang J, Shen Y, Shen Y, et al. Applications of inorganic nanomaterials in photothermal therapy based on combinational cancer treatment. Int J Nanomedicine. 2020;15:1903\u201314.","journal-title":"Int J Nanomedicine"},{"issue":"7","key":"1974_CR22","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202102145","volume":"11","author":"EW Kavanagh","year":"2022","unstructured":"Kavanagh EW, Green JJ. Toward gene transfer nanoparticles as therapeutics. Adv Healthc Mater. 2022;11(7): e2102145.","journal-title":"Adv Healthc Mater"},{"issue":"1","key":"1974_CR23","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/med.21509","volume":"39","author":"F Masse","year":"2019","unstructured":"Masse F, Ouellette M, Lamoureux G, Boisselier E. Gold nanoparticles in ophthalmology. Med Res Rev. 2019;39(1):302\u201327.","journal-title":"Med Res Rev"},{"key":"1974_CR24","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.addr.2019.10.006","volume":"148","author":"FF Sahle","year":"2019","unstructured":"Sahle FF, Kim S, Niloy KK, Tahia F, Fili CV, Cooper E, et al. Nanotechnology in regenerative ophthalmology. Adv Drug Deliv Rev. 2019;148:290\u2013307.","journal-title":"Adv Drug Deliv Rev"},{"issue":"5","key":"1974_CR25","volume":"11","author":"S Gim","year":"2019","unstructured":"Gim S, Zhu Y, Seeberger PH, Delbianco M. Carbohydrate-based nanomaterials for biomedical applications. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2019;11(5): e1558.","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"issue":"4","key":"1974_CR26","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1021\/acsabm.0c01656","volume":"4","author":"AT Thodikayil","year":"2021","unstructured":"Thodikayil AT, Sharma S, Saha S. Engineering carbohydrate-based particles for biomedical applications: strategies to construct and modify. ACS Appl Bio Mater. 2021;4(4):2907\u201340.","journal-title":"ACS Appl Bio Mater"},{"issue":"1","key":"1974_CR27","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1166\/jnn.2014.8904","volume":"14","author":"S Uthaman","year":"2014","unstructured":"Uthaman S, Maya S, Jayakumar R, Cho CS, Park IK. Carbohydrate-based nanogels as drug and gene delivery systems. J Nanosci Nanotechnol. 2014;14(1):694\u2013704.","journal-title":"J Nanosci Nanotechnol"},{"key":"1974_CR28","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijbiomac.2016.04.070","volume":"89","author":"MA Kalam","year":"2016","unstructured":"Kalam MA. Development of chitosan nanoparticles coated with hyaluronic acid for topical ocular delivery of dexamethasone. Int J Biol Macromol. 2016;89:127\u201336.","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"1974_CR29","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3109\/02713689609017609","volume":"15","author":"S Nishikawa","year":"1996","unstructured":"Nishikawa S, Tamai M. Ultrastructure of hyaluronic acid and collagen in the human vitreous. Curr Eye Res. 1996;15(1):37\u201343.","journal-title":"Curr Eye Res"},{"issue":"6","key":"1974_CR30","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1159\/000268042","volume":"29","author":"M Nakagawa","year":"1997","unstructured":"Nakagawa M, Tanaka M, Miyata T. Evaluation of collagen gel and hyaluronic acid as vitreous substitutes. Ophthalmic Res. 1997;29(6):409\u201320.","journal-title":"Ophthalmic Res"},{"issue":"4","key":"1974_CR31","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1089\/jop.2011.0174","volume":"28","author":"O Fulg\u00eancio Gde","year":"2012","unstructured":"Fulg\u00eancio Gde O, Viana FA, Ribeiro RR, Yoshida MI, Faraco AG, Cunha-J\u00fanior AS. New mucoadhesive chitosan film for ophthalmic drug delivery of timolol maleate: in vivo evaluation. J Ocul Pharmacol Ther. 2012;28(4):350\u20138.","journal-title":"J Ocul Pharmacol Ther"},{"key":"1974_CR32","volume":"26","author":"F Chaharband","year":"2020","unstructured":"Chaharband F, Daftarian N, Kanavi MR, Varshochian R, Hajiramezanali M, Norouzi P, et al. Trimethyl chitosan-hyaluronic acid nano-polyplexes for intravitreal VEGFR-2 siRNA delivery: formulation and in vivo efficacy evaluation. Nanomedicine. 2020;26: 102181.","journal-title":"Nanomedicine"},{"issue":"7","key":"1974_CR33","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3390\/pharmaceutics11070321","volume":"11","author":"RV Moiseev","year":"2019","unstructured":"Moiseev RV, Morrison PWJ, Steele F, Khutoryanskiy VV. penetration enhancers in ocular drug delivery. Pharmaceutics. 2019;11(7):321.","journal-title":"Pharmaceutics."},{"issue":"7","key":"1974_CR34","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/ceo.12950","volume":"45","author":"D Yang","year":"2017","unstructured":"Yang D, So KF, Lo AC. Lycium barbarum polysaccharide extracts preserve retinal function and attenuate inner retinal neuronal damage in a mouse model of transient retinal ischaemia. Clin Exp Ophthalmol. 2017;45(7):717\u201329.","journal-title":"Clin Exp Ophthalmol"},{"issue":"1","key":"1974_CR35","first-page":"809","volume":"17","author":"KJ Chien","year":"2018","unstructured":"Chien KJ, Horng CT, Huang YS, Hsieh YH, Wang CJ, Yang JS, et al. Effects of Lycium barbarum (goji berry) on dry eye disease in rats. Mol Med Rep. 2018;17(1):809\u201318.","journal-title":"Mol Med Rep"},{"issue":"14","key":"1974_CR36","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1167\/iovs.19-27886","volume":"60","author":"Y Lakshmanan","year":"2019","unstructured":"Lakshmanan Y, Wong FSY, Zuo B, So KF, Bui BV, Chan HH. Posttreatment intervention with lycium barbarum polysaccharides is neuroprotective in a rat model of chronic ocular hypertension. Invest Ophthalmol Vis Sci. 2019;60(14):4606\u201318.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1974_CR37","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.yexmp.2018.12.007","volume":"106","author":"Y Liu","year":"2019","unstructured":"Liu Y, Zhang Y. RETRACTED: Lycium barbarum polysaccharides alleviate hydrogen peroxide-induced injury by up-regulation of miR-4295 in human trabecular meshwork cells. Exp Mol Pathol. 2019;106:109\u201315.","journal-title":"Exp Mol Pathol"},{"issue":"8","key":"1974_CR38","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.4103\/1673-5374.274349","volume":"15","author":"L Liu","year":"2020","unstructured":"Liu L, Sha XY, Wu YN, Chen MT, Zhong JX. Lycium barbarum polysaccharides protects retinal ganglion cells against oxidative stress injury. Neural Regen Res. 2020;15(8):1526\u201331.","journal-title":"Neural Regen Res"},{"key":"1974_CR39","volume":"211","author":"HL Wong","year":"2021","unstructured":"Wong HL, Hung LT, Kwok SS, Bu Y, Lin Y, Shum HC, et al. The anti-scarring role of Lycium barbarum polysaccharide on cornea epithelial-stromal injury. Exp Eye Res. 2021;211: 108747.","journal-title":"Exp Eye Res"},{"issue":"13","key":"1974_CR40","first-page":"4568","volume":"21","author":"M Yang","year":"2020","unstructured":"Yang M, So KF, Lo ACY, Lam WC. The Effect of Lycium barbarum polysaccharides on pyroptosis-associated amyloid \u03b2(1\u201340) oligomers-induced adult retinal pigment epithelium 19 cell damage. Int J Mol Sci. 2020;21(13):4568.","journal-title":"Int J Mol Sci."},{"issue":"9\u201310","key":"1974_CR41","first-page":"520","volume":"106","author":"LM Gao","year":"2021","unstructured":"Gao LM, Fu S, Liu F, Wu HB, Li WJ. Astragalus polysaccharide regulates mir-182\/bcl-2 axis to relieve metabolic memory through suppressing mitochondrial damage-mediated apoptosis in retinal pigment epithelial cells. Pharmacology. 2021;106(9\u201310):520\u201333.","journal-title":"Pharmacology"},{"issue":"1","key":"1974_CR42","doi-asserted-by":"crossref","first-page":"BSR20192121","DOI":"10.1042\/BSR20192121","volume":"40","author":"QH Peng","year":"2020","unstructured":"Peng QH, Tong P, Gu LM, Li WJ. Astragalus polysaccharide attenuates metabolic memory-triggered ER stress and apoptosis via regulation of miR-204\/SIRT1 axis in retinal pigment epithelial cells. Biosci Rep. 2020;40(1):BSR20192121.","journal-title":"Biosci Rep."},{"issue":"2","key":"1974_CR43","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.exer.2004.03.009","volume":"79","author":"I Ilieva","year":"2004","unstructured":"Ilieva I, Ohgami K, Shiratori K, Koyama Y, Yoshida K, Kase S, et al. The effects of Ginkgo biloba extract on lipopolysaccharide-induced inflammation in vitro and in vivo. Exp Eye Res. 2004;79(2):181\u20137.","journal-title":"Exp Eye Res"},{"issue":"4","key":"1974_CR44","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3736\/jintegrmed2013037","volume":"11","author":"XS Mi","year":"2013","unstructured":"Mi XS, Zhong JX, Chang RC, So KF. Research advances on the usage of traditional Chinese medicine for neuroprotection in glaucoma. J Integr Med. 2013;11(4):233\u201340.","journal-title":"J Integr Med"},{"issue":"32","key":"1974_CR45","volume":"96","author":"Q Li","year":"2017","unstructured":"Li Q, Chen J, Li Y, Chen T, Zou J, Wang H. Effect of polysaccharide of Dendrobium candidum on proliferation and apoptosis of human corneal epithelial cells in high glucose. Medicine (Baltimore). 2017;96(32): e7773.","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"1974_CR46","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1080\/02713683.2020.1842456","volume":"46","author":"W Feng","year":"2021","unstructured":"Feng W, Yang X, Feng M, Pan H, Liu J, Hu Y, et al. Alginate oligosaccharide prevents against d-galactose-mediated cataract in C57BL\/6J mice via regulating oxidative stress and antioxidant system. Curr Eye Res. 2021;46(6):802\u201310.","journal-title":"Curr Eye Res"},{"issue":"Pt A","key":"1974_CR47","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.ijbiomac.2020.09.234","volume":"165","author":"FS Buosi","year":"2020","unstructured":"Buosi FS, Alaimo A, Di Santo MC, El\u00edas F, Garc\u00eda Li\u00f1ares G, Acebedo SL, et al. Resveratrol encapsulation in high molecular weight chitosan-based nanogels for applications in ocular treatments: impact on human ARPE-19 culture cells. Int J Biol Macromol. 2020;165(Pt A):804\u201321.","journal-title":"Int J Biol Macromol"},{"key":"1974_CR48","doi-asserted-by":"crossref","first-page":"122137","DOI":"10.1016\/j.ijpharm.2022.122137","volume":"625","author":"L Yang","year":"2022","unstructured":"Yang L, Gu T, Xu Y, Liu Y, Zhang Y, Jiang Z, et al. Plant polysaccharides as novel biomaterials for microcapsule construction and therapeutics delivery. Int J Pharm. 2022;625:122137.","journal-title":"Int J Pharm"},{"issue":"7","key":"1974_CR49","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1517\/17425247.2013.766714","volume":"10","author":"F Lai","year":"2013","unstructured":"Lai F, Fadda AM, Sinico C. Liposomes for brain delivery. Expert Opin Drug Deliv. 2013;10(7):1003\u201322.","journal-title":"Expert Opin Drug Deliv"},{"issue":"7","key":"1974_CR50","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1021\/mp500057n","volume":"11","author":"T Zong","year":"2014","unstructured":"Zong T, Mei L, Gao H, Cai W, Zhu P, Shi K, et al. Synergistic dual-ligand doxorubicin liposomes improve targeting and therapeutic efficacy of brain glioma in animals. Mol Pharm. 2014;11(7):2346\u201357.","journal-title":"Mol Pharm"},{"key":"1974_CR51","volume":"178","author":"J Wang","year":"2021","unstructured":"Wang J, Zhu M, Nie G. Biomembrane-based nanostructures for cancer targeting and therapy: from synthetic liposomes to natural biomembranes and membrane-vesicles. Adv Drug Deliv Rev. 2021;178: 113974.","journal-title":"Adv Drug Deliv Rev"},{"issue":"11","key":"1974_CR52","doi-asserted-by":"crossref","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","volume":"15","author":"R Tenchov","year":"2021","unstructured":"Tenchov R, Bird R, Curtze AE, Zhou Q. Lipid nanoparticles\u2500from liposomes to mrna vaccine delivery, a landscape of research diversity and advancement. ACS Nano. 2021;15(11):16982\u20137015.","journal-title":"ACS Nano"},{"issue":"22","key":"1974_CR53","doi-asserted-by":"crossref","first-page":"25126","DOI":"10.1021\/acsami.2c04022","volume":"14","author":"Y Yu","year":"2022","unstructured":"Yu Y, Wang Z, Wu S, Zhu C, Meng X, Li C, et al. Glutathione-sensitive nanoglue platform with effective nucleic acids gluing onto liposomes for photo-gene therapy. ACS Appl Mater Interfaces. 2022;14(22):25126\u201334.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"1","key":"1974_CR54","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2174\/1872210513666181127110413","volume":"13","author":"R Sheoran","year":"2019","unstructured":"Sheoran R, Khokra SL, Chawla V, Dureja H. Recent patents, formulation techniques, classification and characterization of liposomes. Recent Pat Nanotechnol. 2019;13(1):17\u201327.","journal-title":"Recent Pat Nanotechnol"},{"key":"1974_CR55","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jconrel.2017.03.008","volume":"252","author":"Y Singh","year":"2017","unstructured":"Singh Y, Meher JG, Raval K, Khan FA, Chaurasia M, Jain NK, et al. Nanoemulsion: concepts, development and applications in drug delivery. J Control Release. 2017;252:28\u201349.","journal-title":"J Control Release"},{"issue":"3","key":"1974_CR56","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1080\/09273948.2019.1587470","volume":"28","author":"MJ Kang","year":"2020","unstructured":"Kang MJ, Kim YH, Chou M, Hwang J, Cheon EJ, Lee HJ, et al. Evaluation of the efficacy and safety of a novel 0.05% cyclosporin a topical nanoemulsion in primary Sj\u00f6gren\u2019s syndrome dry eye. Ocul Immunol Inflamm. 2020;28(3):370\u20138.","journal-title":"Ocul Immunol Inflamm."},{"issue":"3","key":"1974_CR57","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2174\/157016311796799062","volume":"8","author":"RH M\u00fcller","year":"2011","unstructured":"M\u00fcller RH, Shegokar R, Keck CM. 20 years of lipid nanoparticles (SLN and NLC): present state of development and industrial applications. Curr Drug Discov Technol. 2011;8(3):207\u201327.","journal-title":"Curr Drug Discov Technol"},{"key":"1974_CR58","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ejpb.2018.10.017","volume":"133","author":"A Gordillo-Galeano","year":"2018","unstructured":"Gordillo-Galeano A, Mora-Huertas CE. Solid lipid nanoparticles and nanostructured lipid carriers: a review emphasizing on particle structure and drug release. Eur J Pharm Biopharm. 2018;133:285\u2013308.","journal-title":"Eur J Pharm Biopharm"},{"key":"1974_CR59","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120571","volume":"601","author":"D Guimar\u00e3es","year":"2021","unstructured":"Guimar\u00e3es D, Cavaco-Paulo A, Nogueira E. Design of liposomes as drug delivery system for therapeutic applications. Int J Pharm. 2021;601: 120571.","journal-title":"Int J Pharm"},{"issue":"1","key":"1974_CR60","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0939-6411(00)00087-4","volume":"50","author":"RH M\u00fcller","year":"2000","unstructured":"M\u00fcller RH, M\u00e4der K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery\u2014a review of the state of the art. Eur J Pharm Biopharm. 2000;50(1):161\u201377.","journal-title":"Eur J Pharm Biopharm"},{"issue":"Suppl 1","key":"1974_CR61","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1016\/S0169-409X(02)00118-7","volume":"54","author":"RH M\u00fcller","year":"2002","unstructured":"M\u00fcller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev. 2002;54(Suppl 1):S131\u201355.","journal-title":"Adv Drug Deliv Rev"},{"issue":"2\u20133","key":"1974_CR62","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0169-409X(01)00105-3","volume":"47","author":"W Mehnert","year":"2001","unstructured":"Mehnert W, M\u00e4der K. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev. 2001;47(2\u20133):165\u201396.","journal-title":"Adv Drug Deliv Rev"},{"issue":"Suppl 2","key":"1974_CR63","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/S0928-0987(00)00161-5","volume":"11","author":"DM Lambert","year":"2000","unstructured":"Lambert DM. Rationale and applications of lipids as prodrug carriers. Eur J Pharm Sci. 2000;11(Suppl 2):S15-27.","journal-title":"Eur J Pharm Sci"},{"issue":"19","key":"1974_CR64","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1016\/j.bmc.2005.06.039","volume":"13","author":"Y Wang","year":"2005","unstructured":"Wang Y, Li L, Jiang W, Larrick JW. Synthesis and evaluation of a DHA and 10-hydroxycamptothecin conjugate. Bioorg Med Chem. 2005;13(19):5592\u20139.","journal-title":"Bioorg Med Chem"},{"issue":"7\u20138","key":"1974_CR65","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1080\/10611860701499946","volume":"15","author":"S Zalipsky","year":"2007","unstructured":"Zalipsky S, Saad M, Kiwan R, Ber E, Yu N, Minko T. Antitumor activity of new liposomal prodrug of mitomycin C in multidrug resistant solid tumor: insights of the mechanism of action. J Drug Target. 2007;15(7\u20138):518\u201330.","journal-title":"J Drug Target"},{"key":"1974_CR66","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.msec.2015.11.067","volume":"60","author":"F Masood","year":"2016","unstructured":"Masood F. Polymeric nanoparticles for targeted drug delivery system for cancer therapy. Mater Sci Eng C Mater Biol Appl. 2016;60:569\u201378.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"issue":"9","key":"1974_CR67","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.3390\/molecules23092157","volume":"23","author":"J Ahlawat","year":"2018","unstructured":"Ahlawat J, Henriquez G, Narayan M. Enhancing the delivery of chemotherapeutics: role of biodegradable polymeric nanoparticles. Molecules. 2018;23(9):2157.","journal-title":"Molecules."},{"issue":"3","key":"1974_CR68","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ejpb.2006.11.009","volume":"65","author":"K Letchford","year":"2007","unstructured":"Letchford K, Burt H. A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomes. Eur J Pharm Biopharm. 2007;65(3):259\u201369.","journal-title":"Eur J Pharm Biopharm"},{"key":"1974_CR69","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jconrel.2015.05.279","volume":"211","author":"V Andr\u00e9s-Guerrero","year":"2015","unstructured":"Andr\u00e9s-Guerrero V, Zong M, Ramsay E, Rojas B, Sarkhel S, Gallego B, et al. Novel biodegradable polyesteramide microspheres for controlled drug delivery in ophthalmology. J Control Release. 2015;211:105\u201317.","journal-title":"J Control Release"},{"issue":"3","key":"1974_CR70","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ejpb.2004.09.002","volume":"59","author":"M Teixeira","year":"2005","unstructured":"Teixeira M, Alonso MJ, Pinto MM, Barbosa CM. Development and characterization of PLGA nanospheres and nanocapsules containing xanthone and 3-methoxyxanthone. Eur J Pharm Biopharm. 2005;59(3):491\u2013500.","journal-title":"Eur J Pharm Biopharm"},{"issue":"9","key":"1974_CR71","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1080\/17425247.2020.1783236","volume":"17","author":"R Sun","year":"2020","unstructured":"Sun R, Zhang A, Ge Y, Gou J, Yin T, He H, et al. Ultra-small-size astragaloside-IV loaded lipid nanocapsules eye drops for the effective management of dry age-related macular degeneration. Expert Opin Drug Deliv. 2020;17(9):1305\u201320.","journal-title":"Expert Opin Drug Deliv"},{"issue":"1","key":"1974_CR72","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0378-5173(99)00256-2","volume":"190","author":"O Ishida","year":"1999","unstructured":"Ishida O, Maruyama K, Sasaki K, Iwatsuru M. Size-dependent extravasation and interstitial localization of polyethyleneglycol liposomes in solid tumor-bearing mice. Int J Pharm. 1999;190(1):49\u201356.","journal-title":"Int J Pharm"},{"issue":"7","key":"1974_CR73","doi-asserted-by":"crossref","first-page":"576","DOI":"10.3109\/1061186X.2014.934688","volume":"22","author":"M Yokoyama","year":"2014","unstructured":"Yokoyama M. Polymeric micelles as drug carriers: their lights and shadows. J Drug Target. 2014;22(7):576\u201383.","journal-title":"J Drug Target"},{"key":"1974_CR74","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jconrel.2017.01.012","volume":"248","author":"A Mandal","year":"2017","unstructured":"Mandal A, Bisht R, Rupenthal ID, Mitra AK. Polymeric micelles for ocular drug delivery: from structural frameworks to recent preclinical studies. J Control Release. 2017;248:96\u2013116.","journal-title":"J Control Release"},{"issue":"13","key":"1974_CR75","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1167\/tvst.9.13.34","volume":"9","author":"A Schulz","year":"2020","unstructured":"Schulz A, Rickmann A, Wahl S, Germann A, Stanzel BV, Januschowski K, et al. Alginate- and hyaluronic acid-based hydrogels as vitreous substitutes: an in vitro evaluation. Transl Vis Sci Technol. 2020;9(13):34.","journal-title":"Transl Vis Sci Technol"},{"issue":"2","key":"1974_CR76","doi-asserted-by":"crossref","first-page":"2000181","DOI":"10.1002\/adtp.202000181","volume":"4","author":"H Cho","year":"2021","unstructured":"Cho H, Kambhampati SP, Lai MJ, Zhou L, Lee G, Xie Y, et al. Dendrimer-triamcinolone acetonide reduces neuroinflammation, pathological angiogenesis, and neuroretinal dysfunction in ischemic retinopathy. Adv Ther (Weinh). 2021;4(2):2000181.","journal-title":"Adv Ther (Weinh)."},{"issue":"41","key":"1974_CR77","doi-asserted-by":"crossref","first-page":"45673","DOI":"10.1021\/acsami.0c12410","volume":"12","author":"DM Dos Santos","year":"2020","unstructured":"Dos Santos DM, Correa DS, Medeiros ES, Oliveira JE, Mattoso LHC. Advances in functional polymer nanofibers: from spinning fabrication techniques to recent biomedical applications. ACS Appl Mater Interfaces. 2020;12(41):45673\u2013701.","journal-title":"ACS Appl Mater Interfaces"},{"key":"1974_CR78","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.msec.2014.04.051","volume":"45","author":"D Kai","year":"2014","unstructured":"Kai D, Liow SS, Loh XJ. Biodegradable polymers for electrospinning: towards biomedical applications. Mater Sci Eng C Mater Biol Appl. 2014;45:659\u201370.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"1974_CR79","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2022.213124","volume":"141","author":"D Sakpal","year":"2022","unstructured":"Sakpal D, Gharat S, Momin M. Recent advancements in polymeric nanofibers for ophthalmic drug delivery and ophthalmic tissue engineering. Biomater Adv. 2022;141: 213124.","journal-title":"Biomater Adv"},{"issue":"17","key":"1974_CR80","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1039\/D0TB00271B","volume":"8","author":"S Chen","year":"2020","unstructured":"Chen S, John JV, McCarthy A, Xie J. New forms of electrospun nanofiber materials for biomedical applications. J Mater Chem B. 2020;8(17):3733\u201346.","journal-title":"J Mater Chem B"},{"issue":"5","key":"1974_CR81","doi-asserted-by":"crossref","first-page":"468","DOI":"10.4103\/1735-5362.355196","volume":"17","author":"S Mirzaeei","year":"2022","unstructured":"Mirzaeei S, Faryadras FB, Mehrandish S, Rezaei L, Daneshgar F, Karami A. Development and evaluation of polycaprolactone-based electrospun nanofibers containing timolol maleate as a sustained-release device for treatment of glaucoma: in vivo evaluation in equine eye. Res Pharm Sci. 2022;17(5):468\u201381.","journal-title":"Res Pharm Sci"},{"issue":"12","key":"1974_CR82","doi-asserted-by":"crossref","first-page":"9414","DOI":"10.1016\/j.actbio.2013.07.029","volume":"9","author":"PH Warnke","year":"2013","unstructured":"Warnke PH, Alamein M, Skabo S, Stephens S, Bourke R, Heiner P, et al. Primordium of an artificial Bruch\u2019s membrane made of nanofibers for engineering of retinal pigment epithelium cell monolayers. Acta Biomater. 2013;9(12):9414\u201322.","journal-title":"Acta Biomater"},{"issue":"15","key":"1974_CR83","doi-asserted-by":"crossref","first-page":"8669","DOI":"10.1039\/D0CS00461H","volume":"50","author":"X Wang","year":"2021","unstructured":"Wang X, Zhong X, Li J, Liu Z, Cheng L. Inorganic nanomaterials with rapid clearance for biomedical applications. Chem Soc Rev. 2021;50(15):8669\u2013742.","journal-title":"Chem Soc Rev"},{"issue":"4","key":"1974_CR84","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3390\/ma12040617","volume":"12","author":"J Duli\u0144ska-Litewka","year":"2019","unstructured":"Duli\u0144ska-Litewka J, \u0141azarczyk A, Ha\u0142ubiec P, Szafra\u0144ski O, Karnas K, Karewicz A. Superparamagnetic iron oxide nanoparticles-current and prospective medical applications. Materials (Basel). 2019;12(4):617.","journal-title":"Materials (Basel)."},{"key":"1974_CR85","doi-asserted-by":"crossref","first-page":"6097","DOI":"10.2147\/IJN.S321984","volume":"16","author":"H Wei","year":"2021","unstructured":"Wei H, Hu Y, Wang J, Gao X, Qian X, Tang M. Superparamagnetic iron oxide nanoparticles: cytotoxicity, metabolism, and cellular behavior in biomedicine applications. Int J Nanomedicine. 2021;16:6097\u2013113.","journal-title":"Int J Nanomedicine"},{"key":"1974_CR86","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.actbio.2019.11.027","volume":"102","author":"D Zhi","year":"2020","unstructured":"Zhi D, Yang T, Yang J, Fu S, Zhang S. Targeting strategies for superparamagnetic iron oxide nanoparticles in cancer therapy. Acta Biomater. 2020;102:13\u201334.","journal-title":"Acta Biomater"},{"issue":"1","key":"1974_CR87","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1109\/TMAG.2012.2225829","volume":"49","author":"AE Bashar","year":"2013","unstructured":"Bashar AE, Metcalfe A, Yanai A, Laver C, H\u00e4feli UO, Gregory-Evans CY, et al. Influence of iron oxide nanoparticles on innate and genetically modified secretion profiles of mesenchymal stem cells. IEEE Trans Magn. 2013;49(1):389\u201393.","journal-title":"IEEE Trans Magn"},{"issue":"5","key":"1974_CR88","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1167\/tvst.8.5.18","volume":"8","author":"H Demirci","year":"2019","unstructured":"Demirci H, Slimani N, Pawar M, Kumon RE, Vaishnava P, Besirli CG. Magnetic hyperthermia in y79 retinoblastoma and arpe-19 retinal epithelial cells: tumor selective apoptotic activity of iron oxide nanoparticle. Transl Vis Sci Technol. 2019;8(5):18.","journal-title":"Transl Vis Sci Technol"},{"issue":"11 Suppl","key":"1974_CR89","first-page":"38","volume":"116","author":"Y Amsalem","year":"2007","unstructured":"Amsalem Y, Mardor Y, Feinberg MS, Landa N, Miller L, Daniels D, et al. Iron-oxide labeling and outcome of transplanted mesenchymal stem cells in the infarcted myocardium. Circulation. 2007;116(11 Suppl):38\u201345.","journal-title":"Circulation"},{"issue":"3","key":"1974_CR90","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/08820538.2010.488562","volume":"25","author":"TF Bernardes","year":"2010","unstructured":"Bernardes TF, Bonfioli AA. Blepharitis. Semin Ophthalmol. 2010;25(3):79\u201383.","journal-title":"Semin Ophthalmol"},{"issue":"1","key":"1974_CR91","first-page":"Cd007742","volume":"1","author":"K Lindsley","year":"2017","unstructured":"Lindsley K, Nichols JJ, Dickersin K. Non-surgical interventions for acute internal hordeolum. Cochrane Database Syst Rev. 2017;1(1):Cd007742.","journal-title":"Cochrane Database Syst Rev."},{"issue":"10","key":"1974_CR92","doi-asserted-by":"crossref","first-page":"101042","DOI":"10.1016\/j.disamonth.2020.101042","volume":"66","author":"AA Gordon","year":"2020","unstructured":"Gordon AA, Danek DJ, Phelps PO. Common inflammatory and infectious conditions of the eyelid. Dis Mon. 2020;66(10):101042.","journal-title":"Dis Mon"},{"issue":"4","key":"1974_CR93","first-page":"Cd007742","volume":"4","author":"K Lindsley","year":"2013","unstructured":"Lindsley K, Nichols JJ, Dickersin K. Interventions for acute internal hordeolum. Cochrane Database Syst Rev. 2013;4(4):Cd007742.","journal-title":"Cochrane Database Syst Rev."},{"key":"1974_CR94","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2147\/OPTO.S84795","volume":"8","author":"CM Putnam","year":"2016","unstructured":"Putnam CM. Diagnosis and management of blepharitis: an optometrist\u2019s perspective. Clin Optom (Auckl). 2016;8:71\u20138.","journal-title":"Clin Optom (Auckl)"},{"issue":"5","key":"1974_CR95","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/bjo.76.5.272","volume":"76","author":"V Huber-Spitzy","year":"1992","unstructured":"Huber-Spitzy V, B\u00f6hler-Sommeregger K, Arocker-Mettinger E, Grabner G. Ulcerative blepharitis in atopic patients\u2014is Candida species the causative agent? Br J Ophthalmol. 1992;76(5):272\u20134.","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"1974_CR96","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0025-7125(16)31228-7","volume":"67","author":"M Barza","year":"1983","unstructured":"Barza M, Baum J. Ocular infections. Med Clin North Am. 1983;67(1):131\u201352.","journal-title":"Med Clin North Am"},{"issue":"4","key":"1974_CR97","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0891-5520(20)30481-5","volume":"6","author":"EM Raskin","year":"1992","unstructured":"Raskin EM, Speaker MG, Laibson PR. Blepharitis. Infect Dis Clin North Am. 1992;6(4):777\u201387.","journal-title":"Infect Dis Clin North Am"},{"issue":"3","key":"1974_CR98","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s12016-016-8548-5","volume":"51","author":"PY Ong","year":"2016","unstructured":"Ong PY, Leung DY. Bacterial and viral infections in atopic dermatitis: a comprehensive review. Clin Rev Allergy Immunol. 2016;51(3):329\u201337.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"12","key":"1974_CR99","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1097\/INF.0b013e3181adbcde","volume":"28","author":"AF Nikkels","year":"2009","unstructured":"Nikkels AF, Pi\u00e9rard GE. Occult varicella. Pediatr Infect Dis J. 2009;28(12):1073\u20135.","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"1974_CR100","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1111\/all.14853","volume":"76","author":"S Traidl","year":"2021","unstructured":"Traidl S, Roesner L, Zeitvogel J, Werfel T. Eczema herpeticum in atopic dermatitis. Allergy. 2021;76(10):3017\u201327.","journal-title":"Allergy"},{"issue":"16","key":"1974_CR101","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1001\/jama.2013.280318","volume":"310","author":"AA Azari","year":"2013","unstructured":"Azari AA, Barney NP. Conjunctivitis: a systematic review of diagnosis and treatment. JAMA. 2013;310(16):1721\u20139.","journal-title":"JAMA"},{"issue":"3","key":"1974_CR102","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.pop.2015.05.001","volume":"42","author":"SA Alfonso","year":"2015","unstructured":"Alfonso SA, Fawley JD, Alexa LuX. Conjunctivitis. Prim Care. 2015;42(3):325\u201345.","journal-title":"Prim Care"},{"issue":"3","key":"1974_CR103","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1517\/14728210903103818","volume":"14","author":"C Origlieri","year":"2009","unstructured":"Origlieri C, Bielory L. Emerging drugs for conjunctivitis. Expert Opin Emerg Drugs. 2009;14(3):523\u201336.","journal-title":"Expert Opin Emerg Drugs"},{"issue":"3","key":"1974_CR104","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.jcrs.2010.12.037","volume":"37","author":"DW DelMonte","year":"2011","unstructured":"DelMonte DW, Kim T. Anatomy and physiology of the cornea. J Cataract Refract Surg. 2011;37(3):588\u201398.","journal-title":"J Cataract Refract Surg"},{"issue":"4","key":"1974_CR105","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s41433-020-01339-3","volume":"35","author":"DSJ Ting","year":"2021","unstructured":"Ting DSJ, Ho CS, Deshmukh R, Said DG, Dua HS. Infectious keratitis: an update on epidemiology, causative microorganisms, risk factors, and antimicrobial resistance. Eye (Lond). 2021;35(4):1084\u2013101.","journal-title":"Eye (Lond)"},{"key":"1974_CR106","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.micpath.2016.12.013","volume":"104","author":"S Lakhundi","year":"2017","unstructured":"Lakhundi S, Siddiqui R, Khan NA. Pathogenesis of microbial keratitis. Microb Pathog. 2017;104:97\u2013109.","journal-title":"Microb Pathog"},{"issue":"11","key":"1974_CR107","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.ophtha.2017.05.012","volume":"124","author":"A Austin","year":"2017","unstructured":"Austin A, Lietman T, Rose-Nussbaumer J. Update on the management of infectious keratitis. Ophthalmology. 2017;124(11):1678\u201389.","journal-title":"Ophthalmology"},{"issue":"2","key":"1974_CR108","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2174\/1872213X12666180129165718","volume":"12","author":"AKC Leung","year":"2018","unstructured":"Leung AKC, Hon KL, Wong AHC, Wong AS. Bacterial conjunctivitis in childhood: etiology, clinical manifestations, diagnosis, and management. Recent Pat Inflamm Allergy Drug Discov. 2018;12(2):120\u20137.","journal-title":"Recent Pat Inflamm Allergy Drug Discov"},{"issue":"5","key":"1974_CR109","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/NHH.0000000000000791","volume":"37","author":"KD Harris","year":"2019","unstructured":"Harris KD. Herpes Simplex Virus Keratitis. Home Healthc Now. 2019;37(5):281\u20134.","journal-title":"Home Healthc Now"},{"key":"1974_CR110","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1051\/parasite\/2015010","volume":"22","author":"J Lorenzo-Morales","year":"2015","unstructured":"Lorenzo-Morales J, Khan NA, Walochnik J. An update on Acanthamoeba keratitis: diagnosis, pathogenesis and treatment. Parasite. 2015;22:10.","journal-title":"Parasite"},{"issue":"9827","key":"1974_CR111","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/S0140-6736(12)60437-1","volume":"379","author":"DT Tan","year":"2012","unstructured":"Tan DT, Dart JK, Holland EJ, Kinoshita S. Corneal transplantation. Lancet. 2012;379(9827):1749\u201361.","journal-title":"Lancet"},{"issue":"5","key":"1974_CR112","doi-asserted-by":"crossref","first-page":"620","DOI":"10.4103\/ijo.IJO_22_18","volume":"66","author":"G Iyer","year":"2018","unstructured":"Iyer G, Srinivasan B, Agarwal S, Talele D, Rishi E, Rishi P, et al. Keratoprosthesis: current global scenario and a broad Indian perspective. Indian J Ophthalmol. 2018;66(5):620\u20139.","journal-title":"Indian J Ophthalmol"},{"issue":"2","key":"1974_CR113","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/NHH.0000000000000652","volume":"36","author":"PA Rouen","year":"2018","unstructured":"Rouen PA, White ML. Dry eye disease: prevalence, assessment, and management. Home Healthc Now. 2018;36(2):74\u201383.","journal-title":"Home Healthc Now"},{"issue":"5","key":"1974_CR114","first-page":"71","volume":"112","author":"EM Messmer","year":"2015","unstructured":"Messmer EM. The pathophysiology, diagnosis, and treatment of dry eye disease. Dtsch Arztebl Int. 2015;112(5):71\u201381.","journal-title":"Dtsch Arztebl Int"},{"issue":"3","key":"1974_CR115","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/ICU.0000000000000569","volume":"30","author":"EC O\u2019Neil","year":"2019","unstructured":"O\u2019Neil EC, Henderson M, Massaro-Giordano M, Bunya VY. Advances in dry eye disease treatment. Curr Opin Ophthalmol. 2019;30(3):166\u201378.","journal-title":"Curr Opin Ophthalmol"},{"issue":"12","key":"1974_CR116","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1080\/13543784.2016.1249564","volume":"25","author":"M Nebbioso","year":"2016","unstructured":"Nebbioso M, Fameli V, Gharbiya M, Sacchetti M, Zicari AM, Lambiase A. Investigational drugs in dry eye disease. Expert Opin Investig Drugs. 2016;25(12):1437\u201346.","journal-title":"Expert Opin Investig Drugs"},{"issue":"1","key":"1974_CR117","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1001\/archophthalmol.2011.364","volume":"130","author":"W Stevenson","year":"2012","unstructured":"Stevenson W, Chauhan SK, Dana R. Dry eye disease: an immune-mediated ocular surface disorder. Arch Ophthalmol. 2012;130(1):90\u2013100.","journal-title":"Arch Ophthalmol"},{"issue":"11","key":"1974_CR118","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.3390\/ijms21113962","volume":"21","author":"J Hori","year":"2020","unstructured":"Hori J, Kunishige T, Nakano Y. Immune checkpoints contribute corneal immune privilege: implications for dry eye associated with checkpoint inhibitors. Int J Mol Sci. 2020;21(11):3962.","journal-title":"Int J Mol Sci."},{"issue":"3","key":"1974_CR119","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.cvsm.2004.01.002","volume":"34","author":"CP Moore","year":"2004","unstructured":"Moore CP. Immunomodulating agents. Vet Clin North Am Small Anim Pract. 2004;34(3):725\u201337.","journal-title":"Vet Clin North Am Small Anim Pract"},{"issue":"2","key":"1974_CR120","doi-asserted-by":"crossref","first-page":"190","DOI":"10.4103\/ijo.IJO_646_17","volume":"66","author":"MS Sridhar","year":"2018","unstructured":"Sridhar MS. Anatomy of cornea and ocular surface. Indian J Ophthalmol. 2018;66(2):190\u20134.","journal-title":"Indian J Ophthalmol"},{"key":"1974_CR121","doi-asserted-by":"crossref","first-page":"151485","DOI":"10.1016\/j.aanat.2020.151485","volume":"230","author":"G Atta","year":"2020","unstructured":"Atta G, Tempfer H, Kaser-Eichberger A, Guo Y, Schroedl F, Traweger A, et al. The lymphangiogenic and hemangiogenic privilege of the human sclera. Ann Anat. 2020;230:151485.","journal-title":"Ann Anat"},{"issue":"8","key":"1974_CR122","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jfo.2017.04.007","volume":"40","author":"E H\u00e9ron","year":"2017","unstructured":"H\u00e9ron E, Bourcier T. Scleritis and episcleritis. J Fr Ophtalmol. 2017;40(8):681\u201395.","journal-title":"J Fr Ophtalmol"},{"issue":"9","key":"1974_CR123","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s00347-016-0344-3","volume":"113","author":"C Tappeiner","year":"2016","unstructured":"Tappeiner C, Walscheid K, Heiligenhaus A. Diagnosis and treatment of episcleritis and scleritis. Ophthalmologe. 2016;113(9):797\u2013810.","journal-title":"Ophthalmologe"},{"issue":"88","key":"1974_CR124","first-page":"153","volume":"16","author":"D Wakefield","year":"2013","unstructured":"Wakefield D, Di Girolamo N, Thurau S, Wildner G, McCluskey P. Scleritis: challenges in immunopathogenesis and treatment. Discov Med. 2013;16(88):153\u20137.","journal-title":"Discov Med"},{"key":"1974_CR125","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.623725","volume":"12","author":"CE Egwuagu","year":"2021","unstructured":"Egwuagu CE, Alhakeem SA, Mbanefo EC. Uveitis: molecular pathogenesis and emerging therapies. Front Immunol. 2021;12: 623725.","journal-title":"Front Immunol"},{"issue":"1","key":"1974_CR126","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/09273948.2016.1196713","volume":"26","author":"T Tsirouki","year":"2018","unstructured":"Tsirouki T, Dastiridou A, Symeonidis C, Tounakaki O, Brazitikou I, Kalogeropoulos C, et al. A Focus on the epidemiology of uveitis. Ocul Immunol Inflamm. 2018;26(1):2\u201316.","journal-title":"Ocul Immunol Inflamm"},{"key":"1974_CR127","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000060737","volume":"30","author":"T Schlote","year":"1999","unstructured":"Schlote T, Zierhut M. Ocular hypertension and glaucoma associated with scleritis and uveitis. Aspects of epidemiology, pathogenesis and therapy. Dev Ophthalmol. 1999;30:91\u2013109.","journal-title":"Dev Ophthalmol."},{"key":"1974_CR128","volume":"372","author":"BM Burkholder","year":"2021","unstructured":"Burkholder BM, Jabs DA. Uveitis for the non-ophthalmologist. BMJ. 2021;372: m4979.","journal-title":"BMJ"},{"key":"1974_CR129","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13023-016-0412-4","volume":"11","author":"MM Lavezzo","year":"2016","unstructured":"Lavezzo MM, Sakata VM, Morita C, Rodriguez EE, Abdallah SF, da Silva FT, et al. Vogt-Koyanagi-Harada disease: review of a rare autoimmune disease targeting antigens of melanocytes. Orphanet J Rare Dis. 2016;11:29.","journal-title":"Orphanet J Rare Dis"},{"issue":"5\u20136","key":"1974_CR130","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/BF00163553","volume":"14","author":"NG Bazan","year":"1990","unstructured":"Bazan NG, de Abreu MT, Bazan HE, Belfort RJ. Arachidonic acid cascade and platelet-activating factor in the network of eye inflammatory mediators: therapeutic implications in uveitis. Int Ophthalmol. 1990;14(5\u20136):335\u201344.","journal-title":"Int Ophthalmol"},{"issue":"3","key":"1974_CR131","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0230560","volume":"15","author":"N Bouzid","year":"2020","unstructured":"Bouzid N, Jamilloux Y, Chapurlat R, Pradat P, De Parisot A, Kodjikian L, et al. Impact of systemic treatments on the course of HLA-B27-associated uveitis: a retrospective study of 101 patients. PLoS ONE. 2020;15(3): e0230560.","journal-title":"PLoS ONE"},{"issue":"5","key":"1974_CR132","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0002-9394(14)74731-2","volume":"113","author":"XY Zhang","year":"1992","unstructured":"Zhang XY, Wang XM, Hu TS. Profiling human leukocyte antigens in Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol. 1992;113(5):567\u201372.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"1974_CR133","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4103\/0301-4738.58468","volume":"58","author":"RV Agrawal","year":"2010","unstructured":"Agrawal RV, Murthy S, Sangwan V, Biswas J. Current approach in diagnosis and management of anterior uveitis. Indian J Ophthalmol. 2010;58(1):11\u20139.","journal-title":"Indian J Ophthalmol"},{"issue":"3","key":"1974_CR134","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/ICU.0000000000000559","volume":"30","author":"J Gueudry","year":"2019","unstructured":"Gueudry J, Touhami S, Quartier P, Bodaghi B. Therapeutic advances in juvenile idiopathic arthritis - associated uveitis. Curr Opin Ophthalmol. 2019;30(3):179\u201386.","journal-title":"Curr Opin Ophthalmol"},{"issue":"2","key":"1974_CR135","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000068563","volume":"217","author":"R Schalnus","year":"2003","unstructured":"Schalnus R. Topical nonsteroidal anti-inflammatory therapy in ophthalmology. Ophthalmologica. 2003;217(2):89\u201398.","journal-title":"Ophthalmologica"},{"issue":"1\u20132","key":"1974_CR136","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s40123-014-0023-x","volume":"3","author":"C Castiblanco","year":"2014","unstructured":"Castiblanco C, Foster CS. Review of systemic immunosuppression for autoimmune uveitis. Ophthalmol Ther. 2014;3(1\u20132):17\u201336.","journal-title":"Ophthalmol Ther"},{"issue":"12","key":"1974_CR137","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/jamaophthalmol.2019.3964","volume":"137","author":"DA Jabs","year":"2019","unstructured":"Jabs DA. Antimetabolite therapy for uveitis: methotrexate or mycophenolate? JAMA Ophthalmol. 2019;137(12):1449\u201351.","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"1974_CR138","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1136\/bjo.2006.105601","volume":"91","author":"S Sugita","year":"2007","unstructured":"Sugita S. Intravitreal anti-inflammatory treatment for uveitis. Br J Ophthalmol. 2007;91(2):135\u20136.","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"1974_CR139","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ophtha.2018.08.021","volume":"126","author":"JE Thorne","year":"2019","unstructured":"Thorne JE, Sugar EA, Holbrook JT, Burke AE, Altaweel MM, Vitale AT, et al. Periocular triamcinolone vs. intravitreal triamcinolone vs. intravitreal dexamethasone implant for the treatment of uveitic macular edema: the PeriOcular vs. INTravitreal corticosteroids for uveitic macular edema (POINT) Trial. Ophthalmology. 2019;126(2):283\u201395.","journal-title":"Ophthalmology."},{"key":"1974_CR140","volume":"2013","author":"SM Whitcup","year":"2013","unstructured":"Whitcup SM, Nussenblatt RB, Lightman SL, Hollander DA. Inflammation in retinal disease. Int J Inflam. 2013;2013: 724648.","journal-title":"Int J Inflam"},{"issue":"1","key":"1974_CR141","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3390\/microorganisms8010055","volume":"8","author":"M Munro","year":"2019","unstructured":"Munro M, Yadavalli T, Fonteh C, Arfeen S, Lobo-Chan AM. Cytomegalovirus retinitis in HIV and non-HIV Individuals. Microorganisms. 2019;8(1):55.","journal-title":"Microorganisms."},{"issue":"7","key":"1974_CR142","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1089\/108729100413202","volume":"14","author":"S Jalali","year":"2000","unstructured":"Jalali S, Reed JB, Mizoguchi M, Flynn N, Gordon J, Morse LS. Effect of highly active antiretroviral therapy on the incidence of HIV-related cytomegalovirus retinitis and retinal detachment. AIDS Patient Care STDS. 2000;14(7):343\u20136.","journal-title":"AIDS Patient Care STDS"},{"issue":"2","key":"1974_CR143","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ajo.2010.10.018","volume":"151","author":"DA Jabs","year":"2011","unstructured":"Jabs DA. Cytomegalovirus retinitis and the acquired immunodeficiency syndrome\u2014bench to bedside: LXVII Edward Jackson Memorial Lecture. Am J Ophthalmol. 2011;151(2):198-216.e1.","journal-title":"Am J Ophthalmol"},{"issue":"Suppl 3","key":"1974_CR144","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/ajt.12006","volume":"13","author":"CN Kotton","year":"2013","unstructured":"Kotton CN. CMV: prevention, diagnosis and therapy. Am J Transplant. 2013;13(Suppl 3):24\u201340.","journal-title":"Am J Transplant."},{"issue":"2","key":"1974_CR145","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3129\/i09-262","volume":"45","author":"BJ Langner-Wegscheider","year":"2010","unstructured":"Langner-Wegscheider BJ, ten Dam-van LN, Mura M, Faridpooya K, de Smet MD. Intravitreal ganciclovir in the management of non-AIDS-related human cytomegalovirus retinitis. Can J Ophthalmol. 2010;45(2):157\u201360.","journal-title":"Can J Ophthalmol"},{"issue":"1","key":"1974_CR146","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.survophthal.2020.05.004","volume":"66","author":"GA Datoo O\u2019Keefe","year":"2021","unstructured":"Datoo O\u2019Keefe GA, Rao N. Retinal vasculitis: a framework and proposal for a classification system. Surv Ophthalmol. 2021;66(1):54\u201367.","journal-title":"Surv Ophthalmol"},{"issue":"4","key":"1974_CR147","doi-asserted-by":"crossref","first-page":"202","DOI":"10.4103\/0974-9233.58423","volume":"16","author":"AM Abu El-Asrar","year":"2009","unstructured":"Abu El-Asrar AM, Herbort CP, Tabbara KF. Differential diagnosis of retinal vasculitis. Middle East Afr J Ophthalmol. 2009;16(4):202\u201318.","journal-title":"Middle East Afr J Ophthalmol"},{"issue":"4","key":"1974_CR148","volume":"15","author":"J L\u00f3pez Fontanet","year":"2023","unstructured":"L\u00f3pez Fontanet J, Ayala Rodr\u00edguez SC, Oliver AL. Aflibercept for the treatment of macular edema secondary to idiopathic retinal vasculitis, aneurysms, and neuroretinitis syndrome. Cureus. 2023;15(4): e38154.","journal-title":"Cureus"},{"issue":"7","key":"1974_CR149","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1007\/s10792-021-02204-2","volume":"42","author":"S Zeng","year":"2022","unstructured":"Zeng S, Yang L, Bai F, Liu T, Liu X. Intravitreal dexamethasone implant for noninfectious uveitis in Chinese patients. Int Ophthalmol. 2022;42(7):2063\u20139.","journal-title":"Int Ophthalmol"},{"issue":"19","key":"1974_CR150","doi-asserted-by":"crossref","first-page":"4755","DOI":"10.3390\/ijms20194755","volume":"20","author":"H Youngblood","year":"2019","unstructured":"Youngblood H, Robinson R, Sharma A, Sharma S. Proteomic biomarkers of retinal inflammation in diabetic retinopathy. Int J Mol Sci. 2019;20(19):4755.","journal-title":"Int J Mol Sci."},{"issue":"9","key":"1974_CR151","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137358","volume":"10","author":"M Takeuchi","year":"2015","unstructured":"Takeuchi M, Sato T, Tanaka A, Muraoka T, Taguchi M, Sakurai Y, et al. Elevated levels of cytokines associated with Th2 and Th17 cells in vitreous fluid of proliferative diabetic retinopathy patients. PLoS ONE. 2015;10(9): e0137358.","journal-title":"PLoS ONE"},{"issue":"12","key":"1974_CR152","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.3390\/cells11121950","volume":"11","author":"MZ Chauhan","year":"2022","unstructured":"Chauhan MZ, Rather PA, Samarah SM, Elhusseiny AM, Sallam AB. Current and novel therapeutic approaches for treatment of diabetic macular edema. Cells. 2022;11(12):1950.","journal-title":"Cells."},{"key":"1974_CR153","doi-asserted-by":"crossref","first-page":"8374647","DOI":"10.1155\/2018\/8374647","volume":"2018","author":"LF Hern\u00e1ndez-Zimbr\u00f3n","year":"2018","unstructured":"Hern\u00e1ndez-Zimbr\u00f3n LF, Zamora-Alvarado R, Ochoa-De la Paz L, Velez-Montoya R, Zenteno E, Gulias-Ca\u00f1izo R, et al. Age-related macular degeneration: new paradigms for treatment and management of AMD. Oxid Med Cell Longev. 2018;2018:8374647.","journal-title":"Oxid Med Cell Longev."},{"key":"1974_CR154","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1479-5876-9-1","volume":"9","author":"B Liu","year":"2011","unstructured":"Liu B, Wei L, Meyerle C, Tuo J, Sen HN, Li Z, et al. Complement component C5a promotes expression of IL-22 and IL-17 from human T cells and its implication in age-related macular degeneration. J Transl Med. 2011;9:1\u201312.","journal-title":"J Transl Med"},{"issue":"21","key":"1974_CR155","doi-asserted-by":"crossref","first-page":"11837","DOI":"10.3390\/ijms222111837","volume":"22","author":"YK Cho","year":"2021","unstructured":"Cho YK, Park DH, Jeon IC. Medication Trends for Age-Related Macular Degeneration. Int J Mol Sci. 2021;22(21):11837.","journal-title":"Int J Mol Sci."},{"key":"1974_CR156","doi-asserted-by":"crossref","first-page":"8627","DOI":"10.1038\/srep08627","volume":"5","author":"N Vakalis","year":"2015","unstructured":"Vakalis N, Echiadis G, Pervena A, Deligiannis I, Kavalarakis E, Giannikakis S, et al. Intravitreal combination of dexamethasone sodium phosphate and bevacizumab in the treatment of exudative AMD. Sci Rep. 2015;5:8627.","journal-title":"Sci Rep"},{"issue":"12","key":"1974_CR157","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1517\/14656566.2012.690736","volume":"13","author":"DF Kiernan","year":"2012","unstructured":"Kiernan DF, Mieler WF. Intraocular corticosteroids for posterior segment disease: 2012 update. Expert Opin Pharmacother. 2012;13(12):1679\u201394.","journal-title":"Expert Opin Pharmacother"},{"issue":"7","key":"1974_CR158","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/eye.2011.81","volume":"25","author":"D Pau","year":"2011","unstructured":"Pau D, Al Zubidi N, Yalamanchili S, Plant GT, Lee AG. Optic neuritis. Eye (Lond). 2011;25(7):833\u201342.","journal-title":"Eye (Lond)"},{"issue":"24","key":"1974_CR159","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1056\/NEJM199312093292403","volume":"329","author":"RW Beck","year":"1993","unstructured":"Beck RW, Cleary PA, Trobe JD, Kaufman DI, Kupersmith MJ, Paty DW, et al. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The optic neuritis study group. N Engl J Med. 1993;329(24):1764\u20139.","journal-title":"N Engl J Med."},{"key":"1974_CR160","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/978-3-319-47861-6_7","volume":"958","author":"AO Dulamea","year":"2017","unstructured":"Dulamea AO. Role of oligodendrocyte dysfunction in demyelination, remyelination and neurodegeneration in multiple sclerosis. Adv Exp Med Biol. 2017;958:91\u2013127.","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"1974_CR161","doi-asserted-by":"crossref","first-page":"e20190460","DOI":"10.1084\/jem.20190460","volume":"217","author":"CA Wagner","year":"2020","unstructured":"Wagner CA, Roqu\u00e9 PJ, Goverman JM. Pathogenic T cell cytokines in multiple sclerosis. J Exp Med. 2020;217(1):e20190460.","journal-title":"J Exp Med."},{"issue":"13","key":"1974_CR162","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1056\/NEJM200009283431307","volume":"343","author":"JH Noseworthy","year":"2000","unstructured":"Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med. 2000;343(13):938\u201352.","journal-title":"N Engl J Med"},{"issue":"Pt 9","key":"1974_CR163","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1093\/brain\/124.9.1813","volume":"124","author":"N Evangelou","year":"2001","unstructured":"Evangelou N, Konz D, Esiri MM, Smith S, Palace J, Matthews PM. Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis. Brain. 2001;124(Pt 9):1813\u201320.","journal-title":"Brain"},{"issue":"5","key":"1974_CR164","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/bpa.12193","volume":"25","author":"AR Jennings","year":"2015","unstructured":"Jennings AR, Carroll WM. Oligodendrocyte Lineage Cells in Chronic Demyelination of Multiple Sclerosis Optic Nerve. Brain Pathol. 2015;25(5):517\u201330.","journal-title":"Brain Pathol"},{"issue":"2","key":"1974_CR165","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85(2):177\u201389.","journal-title":"Neurology"},{"issue":"2","key":"1974_CR166","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/cei.12271","volume":"176","author":"S Jarius","year":"2014","unstructured":"Jarius S, Wildemann B, Paul F. Neuromyelitis optica: clinical features, immunopathogenesis and treatment. Clin Exp Immunol. 2014;176(2):149\u201364.","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"1974_CR167","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/WNO.0000000000000508","volume":"37","author":"JL Bennett","year":"2017","unstructured":"Bennett JL, Owens GP. Neuromyelitis optica: deciphering a complex immune-mediated astrocytopathy. J Neuroophthalmol. 2017;37(3):291\u20139.","journal-title":"J Neuroophthalmol"},{"key":"1974_CR168","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.msard.2018.11.008","volume":"27","author":"S Shahmohammadi","year":"2019","unstructured":"Shahmohammadi S, Doosti R, Shahmohammadi A, Mohammadianinejad SE, Sahraian MA, Azimi AR, et al. Autoimmune diseases associated with neuromyelitis optica spectrum disorders: a literature review. Mult Scler Relat Disord. 2019;27:350\u201363.","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"1974_CR169","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/1352458511431077","volume":"18","author":"DM Wingerchuk","year":"2012","unstructured":"Wingerchuk DM, Weinshenker BG. The emerging relationship between neuromyelitis optica and systemic rheumatologic autoimmune disease. Mult Scler. 2012;18(1):5\u201310.","journal-title":"Mult Scler"},{"issue":"37","key":"1974_CR170","first-page":"616","volume":"112","author":"H Wilhelm","year":"2015","unstructured":"Wilhelm H, Schabet M. The diagnosis and treatment of optic neuritis. Dtsch Arztebl Int. 2015;112(37):616\u201325.","journal-title":"Dtsch Arztebl Int."},{"issue":"43","key":"1974_CR171","doi-asserted-by":"crossref","first-page":"6759","DOI":"10.1039\/C9TB01066A","volume":"7","author":"Q Zheng","year":"2019","unstructured":"Zheng Q, Fang Y, Zeng L, Li X, Chen H, Song H, et al. Cytocompatible cerium oxide-mediated antioxidative stress in inhibiting ocular inflammation-associated corneal neovascularization. J Mater Chem B. 2019;7(43):6759\u201369.","journal-title":"J Mater Chem B"},{"key":"1974_CR172","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1600-0447.1988.tb09009.x","volume":"344","author":"I Ehiobuche","year":"1988","unstructured":"Ehiobuche I. Obsessive-compulsive neurosis in relation to parental child-rearing patterns amongst the Greek, Italian, and Anglo-Australian subjects. Acta Psychiatr Scand Suppl. 1988;344:115\u201320.","journal-title":"Acta Psychiatr Scand Suppl"},{"issue":"16","key":"1974_CR173","doi-asserted-by":"crossref","first-page":"5362","DOI":"10.1039\/D0DT00924E","volume":"49","author":"U Qumar","year":"2020","unstructured":"Qumar U, Ikram M, Imran M, Haider A, Ul-Hamid A, Haider J, et al. Synergistic effect of Bi-doped exfoliated MoS(2) nanosheets on their bactericidal and dye degradation potential. Dalton Trans. 2020;49(16):5362\u201377.","journal-title":"Dalton Trans"},{"key":"1974_CR174","doi-asserted-by":"crossref","first-page":"160","DOI":"10.12659\/AOT.906856","volume":"23","author":"T R\u00f6ck","year":"2018","unstructured":"R\u00f6ck T, Bartz-Schmidt KU, Landenberger J, Bramkamp M, R\u00f6ck D. Amniotic membrane transplantation in reconstructive and regenerative ophthalmology. Ann Transplant. 2018;23:160\u20135.","journal-title":"Ann Transplant"},{"key":"1974_CR175","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.msec.2017.03.305","volume":"77","author":"RS Bhattarai","year":"2017","unstructured":"Bhattarai RS, Das A, Alzhrani RM, Kang D, Bhaduri SB, Boddu SHS. Comparison of electrospun and solvent cast polylactic acid (PLA)\/poly(vinyl alcohol) (PVA) inserts as potential ocular drug delivery vehicles. Mater Sci Eng C Mater Biol Appl. 2017;77:895\u2013903.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"issue":"3","key":"1974_CR176","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S1542-0124(12)70039-3","volume":"4","author":"S Selvam","year":"2006","unstructured":"Selvam S, Thomas PB, Yiu SC. Tissue engineering: current and future approaches to ocular surface reconstruction. Ocul Surf. 2006;4(3):120\u201336.","journal-title":"Ocul Surf"},{"issue":"10","key":"1974_CR177","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201701328","volume":"7","author":"R Williams","year":"2018","unstructured":"Williams R, Lace R, Kennedy S, Doherty K, Levis H. Biomaterials for regenerative medicine approaches for the anterior segment of the eye. Adv Healthc Mater. 2018;7(10): e1701328.","journal-title":"Adv Healthc Mater"},{"key":"1974_CR178","volume":"111","author":"D Yan","year":"2020","unstructured":"Yan D, Yao Q, Yu F, Chen L, Zhang S, Sun H, et al. Surface modified electrospun poly(lactic acid) fibrous scaffold with cellulose nanofibrils and Ag nanoparticles for ocular cell proliferation and antimicrobial application. Mater Sci Eng C Mater Biol Appl. 2020;111: 110767.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"issue":"18","key":"1974_CR179","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1016\/j.biomaterials.2008.03.014","volume":"29","author":"EG Heckert","year":"2008","unstructured":"Heckert EG, Karakoti AS, Seal S, Self WT. The role of cerium redox state in the SOD mimetic activity of nanoceria. Biomaterials. 2008;29(18):2705\u20139.","journal-title":"Biomaterials"},{"issue":"2","key":"1974_CR180","volume":"6","author":"X Zhou","year":"2011","unstructured":"Zhou X, Wong LL, Karakoti AS, Seal S, McGinnis JF. Nanoceria inhibit the development and promote the regression of pathologic retinal neovascularization in the Vldlr knockout mouse. PLoS ONE. 2011;6(2): e16733.","journal-title":"PLoS ONE"},{"key":"1974_CR181","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.exer.2013.08.003","volume":"116","author":"SV Kyosseva","year":"2013","unstructured":"Kyosseva SV, Chen L, Seal S, McGinnis JF. Nanoceria inhibit expression of genes associated with inflammation and angiogenesis in the retina of Vldlr null mice. Exp Eye Res. 2013;116:63\u201374.","journal-title":"Exp Eye Res"},{"issue":"1","key":"1974_CR182","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.biomaterials.2013.10.022","volume":"35","author":"X Cai","year":"2014","unstructured":"Cai X, Seal S, McGinnis JF. Sustained inhibition of neovascularization in vldlr\/mice following intravitreal injection of cerium oxide nanoparticles and the role of the ASK1-P38\/JNK-NF-\u03baB pathway. Biomaterials. 2014;35(1):249\u201358.","journal-title":"Biomaterials"},{"key":"1974_CR183","doi-asserted-by":"crossref","first-page":"4041767","DOI":"10.1155\/2016\/4041767","volume":"2016","author":"A Vega-Estrada","year":"2016","unstructured":"Vega-Estrada A, Silvestre-Albero J, Rodriguez AE, Rodriguez-Reinoso F, Gomez-Tejedor JA, Antolinos-Turpin CM, et al. Biocompatibility and biomechanical effect of single wall carbon nanotubes implanted in the corneal stroma: a proof of concept investigation. J Ophthalmol. 2016;2016:4041767.","journal-title":"J Ophthalmol"},{"issue":"14","key":"1974_CR184","doi-asserted-by":"crossref","first-page":"eabf7194","DOI":"10.1126\/sciadv.abf7194","volume":"7","author":"J Jang","year":"2021","unstructured":"Jang J, Kim J, Shin H, Park YG, Joo BJ, Seo H, et al. Smart contact lens and transparent heat patch for remote monitoring and therapy of chronic ocular surface inflammation using mobiles. Sci Adv. 2021;7(14):eabf7194.","journal-title":"Sci Adv."},{"issue":"8","key":"1974_CR185","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/01.ico.0000133997.07144.9e","volume":"23","author":"KK Nichols","year":"2004","unstructured":"Nichols KK, Nichols JJ, Mitchell GL. The lack of association between signs and symptoms in patients with dry eye disease. Cornea. 2004;23(8):762\u201370.","journal-title":"Cornea"},{"issue":"35","key":"1974_CR186","doi-asserted-by":"crossref","first-page":"eabb7878","DOI":"10.1126\/sciadv.abb7878","volume":"6","author":"R Ganugula","year":"2020","unstructured":"Ganugula R, Arora M, Lepiz MA, Niu Y, Mallick BK, Pflugfelder SC, et al. Systemic anti-inflammatory therapy aided by double-headed nanoparticles in a canine model of acute intraocular inflammation. Sci Adv. 2020;6(35):eabb7878.","journal-title":"Sci Adv."},{"issue":"9","key":"1974_CR187","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.3390\/ijms19092830","volume":"19","author":"CH Tsai","year":"2018","unstructured":"Tsai CH, Wang PY, Lin IC, Huang H, Liu GS, Tseng CL. Ocular drug delivery: role of degradable polymeric nanocarriers for ophthalmic application. Int J Mol Sci. 2018;19(9):2830.","journal-title":"Int J Mol Sci."},{"issue":"3","key":"1974_CR188","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jconrel.2009.02.020","volume":"136","author":"K Hironaka","year":"2009","unstructured":"Hironaka K, Inokuchi Y, Tozuka Y, Shimazawa M, Hara H, Takeuchi H. Design and evaluation of a liposomal delivery system targeting the posterior segment of the eye. J Control Release. 2009;136(3):247\u201353.","journal-title":"J Control Release"},{"issue":"6","key":"1974_CR189","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1167\/iovs.09-4697","volume":"51","author":"Y Inokuchi","year":"2010","unstructured":"Inokuchi Y, Hironaka K, Fujisawa T, Tozuka Y, Tsuruma K, Shimazawa M, et al. Physicochemical properties affecting retinal drug\/coumarin-6 delivery from nanocarrier systems via eyedrop administration. Invest Ophthalmol Vis Sci. 2010;51(6):3162\u201370.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"1974_CR190","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1080\/10837450.2019.1578370","volume":"24","author":"M Alami-Milani","year":"2019","unstructured":"Alami-Milani M, Zakeri-Milani P, Valizadeh H, Sattari S, Salatin S, Jelvehgari M. Evaluation of anti-inflammatory impact of dexamethasone-loaded PCL-PEG-PCL micelles on endotoxin-induced uveitis in rabbits. Pharm Dev Technol. 2019;24(6):680\u20138.","journal-title":"Pharm Dev Technol"},{"issue":"1","key":"1974_CR191","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejpb.2012.12.010","volume":"84","author":"A Sabzevari","year":"2013","unstructured":"Sabzevari A, Adibkia K, Hashemi H, Hedayatfar A, Mohsenzadeh N, Atyabi F, et al. Polymeric triamcinolone acetonide nanoparticles as a new alternative in the treatment of uveitis: in vitro and in vivo studies. Eur J Pharm Biopharm. 2013;84(1):63\u201371.","journal-title":"Eur J Pharm Biopharm"},{"key":"1974_CR192","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2020.110902","volume":"190","author":"P Nirbhavane","year":"2020","unstructured":"Nirbhavane P, Sharma G, Singh B, Begum G, Jones MC, Rauz S, et al. Triamcinolone acetonide loaded-cationic nano-lipoidal formulation for uveitis: evidences of improved biopharmaceutical performance and anti-inflammatory activity. Colloids Surf B Biointerfaces. 2020;190: 110902.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"1974_CR193","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ajo.2021.09.008","volume":"235","author":"P Liberman","year":"2022","unstructured":"Liberman P, Burkholder BM, Thorne JE, Berkenstock MK. Effectiveness of Difluprednate for the Treatment of Anterior Scleritis. Am J Ophthalmol. 2022;235:172\u20137.","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"1974_CR194","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-026752","volume":"9","author":"MT KhalafAllah","year":"2019","unstructured":"KhalafAllah MT, Basiony A, Salama A. Difluprednate versus Prednisolone Acetate after Cataract Surgery: a Systematic Review and Meta-Analysis. BMJ Open. 2019;9(11): e026752.","journal-title":"BMJ Open"},{"issue":"3","key":"1974_CR195","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3109\/02713683.2012.745879","volume":"38","author":"K Kesavan","year":"2013","unstructured":"Kesavan K, Kant S, Singh PN, Pandit JK. Mucoadhesive chitosan-coated cationic microemulsion of dexamethasone for ocular delivery: in vitro and in vivo evaluation. Curr Eye Res. 2013;38(3):342\u201352.","journal-title":"Curr Eye Res"},{"issue":"12","key":"1974_CR196","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3109\/02713683.2010.508867","volume":"35","author":"F Rafie","year":"2010","unstructured":"Rafie F, Javadzadeh Y, Javadzadeh AR, Ghavidel LA, Jafari B, Moogooee M, et al. In vivo evaluation of novel nanoparticles containing dexamethasone for ocular drug delivery on rabbit eye. Curr Eye Res. 2010;35(12):1081\u20139.","journal-title":"Curr Eye Res"},{"issue":"4","key":"1974_CR197","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1089\/jop.2014.0152","volume":"31","author":"S Patel","year":"2015","unstructured":"Patel S, Garapati C, Chowdhury P, Gupta H, Nesamony J, Nauli S, et al. Development and evaluation of dexamethasone nanomicelles with potential for treating posterior uveitis after topical application. J Ocul Pharmacol Ther. 2015;31(4):215\u201327.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"5","key":"1974_CR198","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1211\/jpp.59.5.0002","volume":"59","author":"T Loftsson","year":"2007","unstructured":"Loftsson T, Hreinsd\u00f3ttir D, Stef\u00e1nsson E. Cyclodextrin microparticles for drug delivery to the posterior segment of the eye: aqueous dexamethasone eye drops. J Pharm Pharmacol. 2007;59(5):629\u201335.","journal-title":"J Pharm Pharmacol"},{"issue":"1","key":"1974_CR199","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jconrel.2012.01.032","volume":"160","author":"P Chopra","year":"2012","unstructured":"Chopra P, Hao J, Li SK. Sustained release micellar carrier systems for iontophoretic transport of dexamethasone across human sclera. J Control Release. 2012;160(1):96\u2013104.","journal-title":"J Control Release"},{"key":"1974_CR200","doi-asserted-by":"crossref","first-page":"591","DOI":"10.2147\/IJN.S179118","volume":"14","author":"X Yu","year":"2019","unstructured":"Yu X, Zhang R, Lei L, Song Q, Li X. High drug payload nanoparticles formed from dexamethasone-peptide conjugates for the treatment of endotoxin-induced uveitis in rabbit. Int J Nanomedicine. 2019;14:591\u2013603.","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"1974_CR201","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/pharmaceutics14010012","volume":"14","author":"E Kickov\u00e1","year":"2021","unstructured":"Kickov\u00e1 E, Sadeghi A, Puranen J, Tavakoli S, Sen M, Ranta VP, et al. Pharmacokinetics of pullulan-dexamethasone conjugates in retinal drug delivery. Pharmaceutics. 2021;14(1):12.","journal-title":"Pharmaceutics."},{"issue":"3","key":"1974_CR202","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.biomaterials.2011.10.010","volume":"33","author":"R Iezzi","year":"2012","unstructured":"Iezzi R, Guru BR, Glybina IV, Mishra MK, Kennedy A, Kannan RM. Dendrimer-based targeted intravitreal therapy for sustained attenuation of neuroinflammation in retinal degeneration. Biomaterials. 2012;33(3):979\u201388.","journal-title":"Biomaterials"},{"issue":"3","key":"1974_CR203","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0378-5173(94)90243-7","volume":"110","author":"AK Zimmer","year":"1994","unstructured":"Zimmer AK, Maincent P, Thouvenot P, Kreuter J. Hydrocortisone delivery to healthy and inflamed eyes using a micellar polysorbate 80 solution or albumin nanoparticles. Int J Pharm. 1994;110(3):211\u201322.","journal-title":"Int J Pharm"},{"issue":"1\u20132","key":"1974_CR204","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ijpharm.2005.05.036","volume":"301","author":"M Yamaguchi","year":"2005","unstructured":"Yamaguchi M, Yasueda S, Isowaki A, Yamamoto M, Kimura M, Inada K, et al. Formulation of an ophthalmic lipid emulsion containing an anti-inflammatory steroidal drug, difluprednate. Int J Pharm. 2005;301(1\u20132):121\u20138.","journal-title":"Int J Pharm"},{"issue":"1\u20132","key":"1974_CR205","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijpharm.2009.05.028","volume":"378","author":"C Civiale","year":"2009","unstructured":"Civiale C, Licciardi M, Cavallaro G, Giammona G, Mazzone MG. Polyhydroxyethylaspartamide-based micelles for ocular drug delivery. Int J Pharm. 2009;378(1\u20132):177\u201386.","journal-title":"Int J Pharm"},{"issue":"4","key":"1974_CR206","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1208\/s12249-016-0589-9","volume":"18","author":"OAE Soliman","year":"2017","unstructured":"Soliman OAE, Mohamed EAM, El-Dahan MS, Khatera NAA. Potential use of cyclodextrin complexes for enhanced stability, anti-inflammatory efficacy, and ocular bioavailability of loteprednol etabonate. AAPS PharmSciTech. 2017;18(4):1228\u201341.","journal-title":"AAPS PharmSciTech"},{"key":"1974_CR207","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2147\/DDDT.S91730","volume":"10","author":"HF Salem","year":"2016","unstructured":"Salem HF, Ahmed SM, Omar MM. Liposomal flucytosine capped with gold nanoparticle formulations for improved ocular delivery. Drug Des Devel Ther. 2016;10:277\u201395.","journal-title":"Drug Des Devel Ther"},{"key":"1974_CR208","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.actbio.2021.10.047","volume":"138","author":"X Sun","year":"2022","unstructured":"Sun X, Sheng Y, Li K, Sai S, Feng J, Li Y, et al. Mucoadhesive phenylboronic acid conjugated chitosan oligosaccharide-vitamin E copolymer for topical ocular delivery of voriconazole: synthesis, in vitro\/vivo evaluation, and mechanism. Acta Biomater. 2022;138:193\u2013207.","journal-title":"Acta Biomater"},{"issue":"6","key":"1974_CR209","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1097\/ICO.0000000000000825","volume":"35","author":"LM Andrade","year":"2016","unstructured":"Andrade LM, Rocha KA, De S\u00e1 FA, Marreto RN, Lima EM, Gratieri T, et al. Voriconazole-Loaded Nanostructured Lipid Carriers for Ocular Drug Delivery. Cornea. 2016;35(6):866\u201371.","journal-title":"Cornea"},{"issue":"8","key":"1974_CR210","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1755-3768.2009.01584.x","volume":"88","author":"FS Habib","year":"2010","unstructured":"Habib FS, Fouad EA, Abdel-Rhaman MS, Fathalla D. Liposomes as an ocular delivery system of fluconazole: in-vitro studies. Acta Ophthalmol. 2010;88(8):901\u20134.","journal-title":"Acta Ophthalmol"},{"issue":"1\u20132","key":"1974_CR211","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ijpharm.2012.12.049","volume":"443","author":"SA Tayel","year":"2013","unstructured":"Tayel SA, El-Nabarawi MA, Tadros MI, Abd-Elsalam WH. Promising ion-sensitive in situ ocular nanoemulsion gels of terbinafine hydrochloride: design, in vitro characterization and in vivo estimation of the ocular irritation and drug pharmacokinetics in the aqueous humor of rabbits. Int J Pharm. 2013;443(1\u20132):293\u2013305.","journal-title":"Int J Pharm"},{"issue":"1","key":"1974_CR212","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1208\/s12249-009-9373-4","volume":"11","author":"KM Hosny","year":"2010","unstructured":"Hosny KM. Ciprofloxacin as ocular liposomal hydrogel. AAPS PharmSciTech. 2010;11(1):241\u20136.","journal-title":"AAPS PharmSciTech"},{"key":"1974_CR213","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ijbiomac.2015.12.077","volume":"85","author":"MS Baig","year":"2016","unstructured":"Baig MS, Ahad A, Aslam M, Imam SS, Aqil M, Ali A. Application of Box-Behnken design for preparation of levofloxacin-loaded stearic acid solid lipid nanoparticles for ocular delivery: optimization, in vitro release, ocular tolerance, and antibacterial activity. Int J Biol Macromol. 2016;85:258\u201370.","journal-title":"Int J Biol Macromol"},{"issue":"11","key":"1974_CR214","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1517\/17425247.2015.1059419","volume":"12","author":"N \u00dcst\u00fcnda\u011f-Okur","year":"2015","unstructured":"\u00dcst\u00fcnda\u011f-Okur N, G\u00f6k\u00e7e EH, Bozb\u0131y\u0131k D, E\u011frilmez S, Ertan G, \u00d6zer \u00d6. Novel nanostructured lipid carrier-based inserts for controlled ocular drug delivery: evaluation of corneal bioavailability and treatment efficacy in bacterial keratitis. Expert Opin Drug Deliv. 2015;12(11):1791\u2013807.","journal-title":"Expert Opin Drug Deliv"},{"issue":"7","key":"1974_CR215","doi-asserted-by":"crossref","first-page":"885","DOI":"10.3109\/10717544.2013.858195","volume":"22","author":"NC Silva","year":"2015","unstructured":"Silva NC, Silva S, Sarmento B, Pintado M. Chitosan nanoparticles for daptomycin delivery in ocular treatment of bacterial endophthalmitis. Drug Deliv. 2015;22(7):885\u201393.","journal-title":"Drug Deliv"},{"key":"1974_CR216","doi-asserted-by":"crossref","first-page":"101496","DOI":"10.1016\/j.jddst.2019.101496","volume":"55","author":"MS Baig","year":"2020","unstructured":"Baig MS, Owida H, Njoroge W, Siddiqui A-u-R, Yang Y. Development and evaluation of cationic nanostructured lipid carriers for ophthalmic drug delivery of besifloxacin. J Drug Deliv Sci Technol. 2020;55:101496.","journal-title":"J Drug Deliv Sci Technol."},{"key":"1974_CR217","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.ijbiomac.2018.05.113","volume":"116","author":"D Liu","year":"2018","unstructured":"Liu D, Lian Y, Fang Q, Liu L, Zhang J, Li J. Hyaluronic-acid-modified lipid-polymer hybrid nanoparticles as an efficient ocular delivery platform for moxifloxacin hydrochloride. Int J Biol Macromol. 2018;116:1026\u201336.","journal-title":"Int J Biol Macromol"},{"key":"1974_CR218","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.111514","volume":"118","author":"A Celebioglu","year":"2021","unstructured":"Celebioglu A, Uyar T. Electrospun formulation of acyclovir\/cyclodextrin nanofibers for fast-dissolving antiviral drug delivery. Mater Sci Eng C Mater Biol Appl. 2021;118: 111514.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"issue":"1\u20132","key":"1974_CR219","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ijpharm.2016.02.015","volume":"502","author":"A Baskakova","year":"2016","unstructured":"Baskakova A, Awwad S, Jim\u00e9nez JQ, Gill H, Novikov O, Khaw PT, et al. Electrospun formulations of acyclovir, ciprofloxacin and cyanocobalamin for ocular drug delivery. Int J Pharm. 2016;502(1\u20132):208\u201318.","journal-title":"Int J Pharm"},{"key":"1974_CR220","doi-asserted-by":"crossref","first-page":"7825","DOI":"10.2147\/IJN.S268208","volume":"15","author":"GA El-Emam","year":"2020","unstructured":"El-Emam GA, Girgis GNS, El-Sokkary MMA, El-Azeem Soliman OA, Abd El Gawad A. Ocular inserts of voriconazole-loaded proniosomal gels: formulation, evaluation and microbiological studies. Int J Nanomedicine. 2020;15:7825\u201340.","journal-title":"Int J Nanomedicine."},{"issue":"7","key":"1974_CR221","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.ophtha.2006.01.059","volume":"113","author":"M Kramer","year":"2006","unstructured":"Kramer M, Kramer MR, Blau H, Bishara J, Axer-Siegel R, Weinberger D. Intravitreal voriconazole for the treatment of endogenous Aspergillus endophthalmitis. Ophthalmology. 2006;113(7):1184\u20136.","journal-title":"Ophthalmology"},{"issue":"4","key":"1974_CR222","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1128\/AAC.37.4.633","volume":"37","author":"I Cochereau-Massin","year":"1993","unstructured":"Cochereau-Massin I, Bauchet J, Marrakchi-Benjaafar S, Saleh-Mghir A, Faurisson F, Vallois JM, et al. Efficacy and ocular penetration of sparfloxacin in experimental streptococcal endophthalmitis. Antimicrob Agents Chemother. 1993;37(4):633\u20136.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"1974_CR223","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1136\/bjo.79.6.606","volume":"79","author":"JP Diamond","year":"1995","unstructured":"Diamond JP, White L, Leeming JP, Hoh HB, Easty DL. Topical ciprofloxacin, norfloxacin, and ofloxacin in treatment of bacterial keratitis: a new method for comparative evaluation of ocular drug penetration. Br J Ophthalmol. 1995;79(6):606\u20139.","journal-title":"Br J Ophthalmol."},{"key":"1974_CR224","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ejpb.2016.10.015","volume":"109","author":"SP Balguri","year":"2016","unstructured":"Balguri SP, Adelli GR, Majumdar S. Topical ophthalmic lipid nanoparticle formulations (SLN, NLC) of indomethacin for delivery to the posterior segment ocular tissues. Eur J Pharm Biopharm. 2016;109:224\u201335.","journal-title":"Eur J Pharm Biopharm"},{"issue":"8","key":"1974_CR225","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1007\/s12272-001-1266-6","volume":"31","author":"AA Badawi","year":"2008","unstructured":"Badawi AA, El-Laithy HM, El Qidra RK, El Mofty H, El dally M. Chitosan based nanocarriers for indomethacin ocular delivery. Arch Pharm Res. 2008;31(8):1040\u20139.","journal-title":"Arch Pharm Res."},{"issue":"2","key":"1974_CR226","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1089\/jop.2012.0069","volume":"29","author":"K Hippalgaonkar","year":"2013","unstructured":"Hippalgaonkar K, Adelli GR, Hippalgaonkar K, Repka MA, Majumdar S. Indomethacin-loaded solid lipid nanoparticles for ocular delivery: development, characterization, and in vitro evaluation. J Ocul Pharmacol Ther. 2013;29(2):216\u201328.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"3","key":"1974_CR227","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3109\/10837450.2015.1125922","volume":"22","author":"H Almeida","year":"2017","unstructured":"Almeida H, Lob\u00e3o P, Frigerio C, Fonseca J, Silva R, Sousa Lobo JM, et al. Preparation, characterization and biocompatibility studies of thermoresponsive eyedrops based on the combination of nanostructured lipid carriers (NLC) and the polymer Pluronic F-127 for controlled delivery of ibuprofen. Pharm Dev Technol. 2017;22(3):336\u201349.","journal-title":"Pharm Dev Technol"},{"issue":"11","key":"1974_CR228","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1002\/jps.20685","volume":"95","author":"E Vega","year":"2006","unstructured":"Vega E, Egea MA, Valls O, Espina M, Garc\u00eda ML. Flurbiprofen loaded biodegradable nanoparticles for ophtalmic administration. J Pharm Sci. 2006;95(11):2393\u2013405.","journal-title":"J Pharm Sci"},{"issue":"1\u20132","key":"1974_CR229","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijpharm.2010.10.013","volume":"403","author":"Q Luo","year":"2011","unstructured":"Luo Q, Zhao J, Zhang X, Pan W. Nanostructured lipid carrier (NLC) coated with chitosan oligosaccharides and its potential use in ocular drug delivery system. Int J Pharm. 2011;403(1\u20132):185\u201391.","journal-title":"Int J Pharm"},{"issue":"2","key":"1974_CR230","doi-asserted-by":"crossref","first-page":"96","DOI":"10.4103\/2230-973X.177823","volume":"6","author":"TA Abdullah","year":"2016","unstructured":"Abdullah TA, Ibrahim NJ, Warsi MH. Chondroitin sulfate-chitosan nanoparticles for ocular delivery of bromfenac sodium: improved permeation, retention, and penetration. Int J Pharm Investig. 2016;6(2):96\u2013105.","journal-title":"Int J Pharm Investig"},{"key":"1974_CR231","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.colsurfb.2016.04.054","volume":"145","author":"E S\u00e1nchez-L\u00f3pez","year":"2016","unstructured":"S\u00e1nchez-L\u00f3pez E, Egea MA, Cano A, Espina M, Calpena AC, Ettcheto M, et al. PEGylated PLGA nanospheres optimized by design of experiments for ocular administration of dexibuprofen-in vitro, ex vivo and in vivo characterization. Colloids Surf B Biointerfaces. 2016;145:241\u201350.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"1\u20132","key":"1974_CR232","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ijpharm.2015.07.010","volume":"492","author":"AH Salama","year":"2015","unstructured":"Salama AH, Shamma RN. Tri\/tetra-block co-polymeric nanocarriers as a potential ocular delivery system of lornoxicam: in-vitro characterization, and in-vivo estimation of corneal permeation. Int J Pharm. 2015;492(1\u20132):28\u201339.","journal-title":"Int J Pharm"},{"issue":"1\u20132","key":"1974_CR233","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ijpharm.2007.12.007","volume":"355","author":"AA Attama","year":"2008","unstructured":"Attama AA, Reichl S, M\u00fcller-Goymann CC. Diclofenac sodium delivery to the eye: in vitro evaluation of novel solid lipid nanoparticle formulation using human cornea construct. Int J Pharm. 2008;355(1\u20132):307\u201313.","journal-title":"Int J Pharm"},{"issue":"1\u20132","key":"1974_CR234","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.ijpharm.2012.07.024","volume":"436","author":"T Fujisawa","year":"2012","unstructured":"Fujisawa T, Miyai H, Hironaka K, Tsukamoto T, Tahara K, Tozuka Y, et al. Liposomal diclofenac eye drop formulations targeting the retina: formulation stability improvement using surface modification of liposomes. Int J Pharm. 2012;436(1\u20132):564\u20137.","journal-title":"Int J Pharm"},{"issue":"10","key":"1974_CR235","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1039\/C7NJ00112F","volume":"41","author":"S Yu","year":"2017","unstructured":"Yu S, Li Q, Li Y, Wang H, Liu D, Yang X, et al. A novel hydrogel with dual temperature and pH responsiveness based on a nanostructured lipid carrier as an ophthalmic delivery system: enhanced trans-corneal permeability and bioavailability of nepafenac. New J Chem. 2017;41(10):3920\u20139.","journal-title":"New J Chem"},{"issue":"6","key":"1974_CR236","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S1773-2247(11)50078-4","volume":"21","author":"F Habib","year":"2011","unstructured":"Habib F, El-Mahdy M, Maher S. Microemulsions for ocular delivery: evaluation and characterization. J Drug Deliv Sci Technol. 2011;21(6):485\u20139.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"1\u20132","key":"1974_CR237","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijpharm.2008.07.017","volume":"363","author":"X Li","year":"2008","unstructured":"Li X, Nie SF, Kong J, Li N, Ju CY, Pan WS. A controlled-release ocular delivery system for ibuprofen based on nanostructured lipid carriers. Int J Pharm. 2008;363(1\u20132):177\u201382.","journal-title":"Int J Pharm"},{"issue":"3","key":"1974_CR238","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0955-2863(01)00208-X","volume":"13","author":"G Ranaldi","year":"2002","unstructured":"Ranaldi G, Marigliano I, Vespignani I, Perozzi G, Sambuy Y. The effect of chitosan and other polycations on tight junction permeability in the human intestinal Caco-2 cell line(1). J Nutr Biochem. 2002;13(3):157\u201367.","journal-title":"J Nutr Biochem"},{"issue":"9","key":"1974_CR239","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1517\/17425240903114142","volume":"6","author":"MC Bonferoni","year":"2009","unstructured":"Bonferoni MC, Sandri G, Rossi S, Ferrari F, Caramella C. Chitosan and its salts for mucosal and transmucosal delivery. Expert Opin Drug Deliv. 2009;6(9):923\u201339.","journal-title":"Expert Opin Drug Deliv"},{"issue":"7","key":"1974_CR240","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1089\/jop.2012.0194","volume":"29","author":"VF Diakonis","year":"2013","unstructured":"Diakonis VF, Tsourdou A, Tzatzarakis MN, Tsika C, Charisis S, Naoumidi I, et al. Evaluation of vitreous clearance and potential retinal toxicity of intravitreal lornoxicam (xefo). J Ocul Pharmacol Ther. 2013;29(7):627\u201332.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"1\u20132","key":"1974_CR241","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ijpharm.2010.11.016","volume":"404","author":"Y Harada","year":"2011","unstructured":"Harada Y, Yamamoto T, Sakai M, Saiki T, Kawano K, Maitani Y, et al. Effects of organic solvents on drug incorporation into polymeric carriers and morphological analyses of drug-incorporated polymeric micelles. Int J Pharm. 2011;404(1\u20132):271\u201380.","journal-title":"Int J Pharm"},{"issue":"10","key":"1974_CR242","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1002\/jps.22137","volume":"99","author":"I Pepi\u0107","year":"2010","unstructured":"Pepi\u0107 I, Hafner A, Lovri\u0107 J, Pirki\u0107 B, Filipovi\u0107-Grci\u0107 J. A nonionic surfactant\/chitosan micelle system in an innovative eye drop formulation. J Pharm Sci. 2010;99(10):4317\u201325.","journal-title":"J Pharm Sci"},{"issue":"9","key":"1974_CR243","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1021\/acs.molpharmaceut.6b00445","volume":"13","author":"S Liu","year":"2016","unstructured":"Liu S, Dozois MD, Chang CN, Ahmad A, Ng DL, Hileeto D, et al. Prolonged ocular retention of mucoadhesive nanoparticle eye drop formulation enables treatment of eye diseases using significantly reduced dosage. Mol Pharm. 2016;13(9):2897\u2013905.","journal-title":"Mol Pharm"},{"issue":"11","key":"1974_CR244","doi-asserted-by":"crossref","first-page":"996","DOI":"10.3109\/02713680903261405","volume":"34","author":"EH G\u00f6k\u00e7e","year":"2009","unstructured":"G\u00f6k\u00e7e EH, Sandri G, E\u011frilmez S, Bonferoni MC, G\u00fcneri T, Caramella C. Cyclosporine a-loaded solid lipid nanoparticles: ocular tolerance and in vivo drug release in rabbit eyes. Curr Eye Res. 2009;34(11):996\u20131003.","journal-title":"Curr Eye Res"},{"issue":"1\u20132","key":"1974_CR245","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ijpharm.2010.10.008","volume":"402","author":"J Shen","year":"2010","unstructured":"Shen J, Deng Y, Jin X, Ping Q, Su Z, Li L. Thiolated nanostructured lipid carriers as a potential ocular drug delivery system for cyclosporine A: Improving in vivo ocular distribution. Int J Pharm. 2010;402(1\u20132):248\u201353.","journal-title":"Int J Pharm"},{"issue":"1\u20132","key":"1974_CR246","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ijpharm.2013.07.002","volume":"455","author":"C Luschmann","year":"2013","unstructured":"Luschmann C, Herrmann W, Strauss O, Luschmann K, Goepferich A. Ocular delivery systems for poorly soluble drugs: an in-vivo evaluation. Int J Pharm. 2013;455(1\u20132):331\u20137.","journal-title":"Int J Pharm"},{"issue":"3","key":"1974_CR247","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1208\/s12249-014-0244-2","volume":"16","author":"K Cholkar","year":"2015","unstructured":"Cholkar K, Gunda S, Earla R, Pal D, Mitra AK. Nanomicellar topical aqueous drop formulation of rapamycin for back-of-the-eye delivery. AAPS PharmSciTech. 2015;16(3):610\u201322.","journal-title":"AAPS PharmSciTech"},{"key":"1974_CR248","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2019.03.022","volume":"562","author":"D Liu","year":"2019","unstructured":"Liu D, Wu Q, Chen W, Lin H, Zhu Y, Liu Y, et al. A novel FK506 loaded nanomicelles consisting of amino-terminated poly(ethylene glycol)-block-poly(D, L)-lactic acid and hydroxypropyl methylcellulose for ocular drug delivery. Int J Pharm. 2019;562:1\u201310.","journal-title":"Int J Pharm"},{"key":"1974_CR249","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ejps.2019.03.023","volume":"133","author":"D Liu","year":"2019","unstructured":"Liu D, Wu Q, Chen W, Lin H, Liu Y, Liang H, et al. Tacrolimus-loaded methoxy poly(ethylene glycol)-block-poly(D, L)-lactic-co-glycolic acid micelles self-assembled in aqueous solution for treating cornea immune rejection after allogenic penetrating keratoplasty in rats. Eur J Pharm Sci. 2019;133:104\u201314.","journal-title":"Eur J Pharm Sci"},{"key":"1974_CR250","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.biopha.2017.07.110","volume":"94","author":"MA Kalam","year":"2017","unstructured":"Kalam MA, Alshamsan A. Poly (d, l-lactide-co-glycolide) nanoparticles for sustained release of tacrolimus in rabbit eyes. Biomed Pharmacother. 2017;94:402\u201311.","journal-title":"Biomed Pharmacother"},{"key":"1974_CR251","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2021.112255","volume":"211","author":"D Modi","year":"2022","unstructured":"Modi D, Nirmal J, Warsi MH, Bhatia M, Hasan N, Kesharwani P, et al. Formulation and development of tacrolimus-gellan gum nanoformulation for treatment of dry eye disease. Colloids Surf B Biointerfaces. 2022;211: 112255.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"8","key":"1974_CR252","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1177\/0885328220977605","volume":"35","author":"MRB Paiva","year":"2021","unstructured":"Paiva MRB, Andrade GF, Dourado LFN, Castro BFM, Fialho SL, Sousa EMB, et al. Surface functionalized mesoporous silica nanoparticles for intravitreal application of tacrolimus. J Biomater Appl. 2021;35(8):1019\u201333.","journal-title":"J Biomater Appl"},{"key":"1974_CR253","volume":"599","author":"MY Badr","year":"2021","unstructured":"Badr MY, Abdulrahman NS, Schatzlein AG, Uchegbu IF. A polymeric aqueous tacrolimus formulation for topical ocular delivery. Int J Pharm. 2021;599: 120364.","journal-title":"Int J Pharm"},{"key":"1974_CR254","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jconrel.2021.03.035","volume":"333","author":"L Rebibo","year":"2021","unstructured":"Rebibo L, Tam C, Sun Y, Shoshani E, Badihi A, Nassar T, et al. Topical tacrolimus nanocapsules eye drops for therapeutic effect enhancement in both anterior and posterior ocular inflammation models. J Control Release. 2021;333:283\u201397.","journal-title":"J Control Release"},{"key":"1974_CR255","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2147\/DDDT.S287721","volume":"15","author":"K Sun","year":"2021","unstructured":"Sun K, Hu K. Preparation and characterization of tacrolimus-loaded SLNs in situ gel for ocular drug delivery for the treatment of immune conjunctivitis. Drug Des Devel Ther. 2021;15:141\u201350.","journal-title":"Drug Des Devel Ther"},{"issue":"2","key":"1974_CR256","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ejpb.2003.10.018","volume":"57","author":"E Gavini","year":"2004","unstructured":"Gavini E, Chetoni P, Cossu M, Alvarez MG, Saettone MF, Giunchedi P. PLGA microspheres for the ocular delivery of a peptide drug, vancomycin using emulsification\/spray-drying as the preparation method: in vitro\/in vivo studies. Eur J Pharm Biopharm. 2004;57(2):207\u201312.","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"1974_CR257","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3109\/10837450903479954","volume":"16","author":"K Yoncheva","year":"2011","unstructured":"Yoncheva K, Vandervoort J, Ludwig A. Development of mucoadhesive poly(lactide-co-glycolide) nanoparticles for ocular application. Pharm Dev Technol. 2011;16(1):29\u201335.","journal-title":"Pharm Dev Technol"},{"issue":"2","key":"1974_CR258","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.nano.2009.10.004","volume":"6","author":"H Gupta","year":"2010","unstructured":"Gupta H, Aqil M, Khar RK, Ali A, Bhatnagar A, Mittal G. Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery. Nanomedicine. 2010;6(2):324\u201333.","journal-title":"Nanomedicine"},{"issue":"12","key":"1974_CR259","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1002\/mabi.201200216","volume":"12","author":"S Liu","year":"2012","unstructured":"Liu S, Jones L, Gu FX. Development of mucoadhesive drug delivery system using phenylboronic acid functionalized poly(D, L-lactide)-b-dextran nanoparticles. Macromol Biosci. 2012;12(12):1622\u20136.","journal-title":"Macromol Biosci"},{"issue":"6","key":"1974_CR260","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2165\/00063030-200013060-00003","volume":"13","author":"J Salzmann","year":"2000","unstructured":"Salzmann J, Lightman S. The potential of newer immunomodulating drugs in the treatment of uveitis: a review. BioDrugs. 2000;13(6):397\u2013408.","journal-title":"BioDrugs"},{"issue":"1","key":"1974_CR261","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/jcp.1041540103","volume":"154","author":"N Terada","year":"1993","unstructured":"Terada N, Lucas JJ, Szepesi A, Franklin RA, Domenico J, Gelfand EW. Rapamycin blocks cell cycle progression of activated T cells prior to events characteristic of the middle to late G1 phase of the cycle. J Cell Physiol. 1993;154(1):7\u201315.","journal-title":"J Cell Physiol"},{"issue":"1","key":"1974_CR262","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1080\/10717544.2019.1582728","volume":"26","author":"Q Wu","year":"2019","unstructured":"Wu Q, Liu D, Zhang X, Wang D, DongYe M, Chen W, et al. Development and effects of tacrolimus-loaded nanoparticles on the inhibition of corneal allograft rejection. Drug Deliv. 2019;26(1):290\u20139.","journal-title":"Drug Deliv"},{"issue":"5","key":"1974_CR263","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.semarthrit.2014.09.012","volume":"44","author":"E Lubrano","year":"2015","unstructured":"Lubrano E, Spadaro A, Amato G, Benucci M, Cavazzana I, Chimenti MS, et al. Tumour necrosis factor alpha inhibitor therapy and rehabilitation for the treatment of ankylosing spondylitis: a systematic review. Semin Arthritis Rheum. 2015;44(5):542\u201350.","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"1974_CR264","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1136\/bjophthalmol-2013-303935","volume":"98","author":"D Doycheva","year":"2014","unstructured":"Doycheva D, Zierhut M, Blumenstock G, Stuebiger N, Januschowski K, Voykov B, et al. Immunomodulatory therapy with tumour necrosis factor \u03b1 inhibitors in children with antinuclear antibody-associated chronic anterior uveitis: long-term results. Br J Ophthalmol. 2014;98(4):523\u20138.","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"1974_CR265","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/j.ophtha.2014.04.042","volume":"121","author":"M Takeuchi","year":"2014","unstructured":"Takeuchi M, Kezuka T, Sugita S, Keino H, Namba K, Kaburaki T, et al. Evaluation of the long-term efficacy and safety of infliximab treatment for uveitis in Beh\u00e7et\u2019s disease: a multicenter study. Ophthalmology. 2014;121(10):1877\u201384.","journal-title":"Ophthalmology"},{"issue":"3","key":"1974_CR266","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.ophtha.2013.09.048","volume":"121","author":"G Levy-Clarke","year":"2014","unstructured":"Levy-Clarke G, Jabs DA, Read RW, Rosenbaum JT, Vitale A, Van Gelder RN. Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders. Ophthalmology. 2014;121(3):785-96.e3.","journal-title":"Ophthalmology"},{"issue":"6","key":"1974_CR267","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.survophthal.2015.06.004","volume":"60","author":"M Cordero-Coma","year":"2015","unstructured":"Cordero-Coma M, Sobrin L. Anti-tumor necrosis factor-\u03b1 therapy in uveitis. Surv Ophthalmol. 2015;60(6):575\u201389.","journal-title":"Surv Ophthalmol"},{"issue":"12","key":"1974_CR268","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1136\/bjophthalmol-2016-310044","volume":"101","author":"R Zhang","year":"2017","unstructured":"Zhang R, Qian J, Li X, Yuan Y. Treatment of experimental autoimmune uveoretinitis with intravitreal injection of infliximab encapsulated in liposomes. Br J Ophthalmol. 2017;101(12):1731\u20138.","journal-title":"Br J Ophthalmol"},{"key":"1974_CR269","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.exer.2018.07.006","volume":"176","author":"J Torrecilla","year":"2018","unstructured":"Torrecilla J, Del Pozo-Rodr\u00edguez A, Vicente-Pascual M, Solin\u00eds M, Rodr\u00edguez-Gasc\u00f3n A. Targeting corneal inflammation by gene therapy: emerging strategies for keratitis. Exp Eye Res. 2018;176:130\u201340.","journal-title":"Exp Eye Res"},{"issue":"9","key":"1974_CR270","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/gt.2008.16","volume":"15","author":"M de la Fuente","year":"2008","unstructured":"de la Fuente M, Seijo B, Alonso MJ. Bioadhesive hyaluronan-chitosan nanoparticles can transport genes across the ocular mucosa and transfect ocular tissue. Gene Ther. 2008;15(9):668\u201376.","journal-title":"Gene Ther"},{"issue":"4","key":"1974_CR271","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1089\/hum.2011.115","volume":"23","author":"D Delgado","year":"2012","unstructured":"Delgado D, del Pozo-Rodr\u00edguez A, Solin\u00eds M, Avil\u00e9s-Triqueros M, Weber BH, Fern\u00e1ndez E, et al. Dextran and protamine-based solid lipid nanoparticles as potential vectors for the treatment of X-linked juvenile retinoschisis. Hum Gene Ther. 2012;23(4):345\u201355.","journal-title":"Hum Gene Ther"},{"issue":"2","key":"1974_CR272","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s00417-005-0070-z","volume":"244","author":"D Bauer","year":"2006","unstructured":"Bauer D, Lu M, Wasmuth S, Li H, Yang Y, Roggendorf M, et al. Immunomodulation by topical particle-mediated administration of cytokine plasmid DNA suppresses herpetic stromal keratitis without impairment of antiviral defense. Graefes Arch Clin Exp Ophthalmol. 2006;244(2):216\u201325.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2","key":"1974_CR273","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1167\/iovs.17-23308","volume":"59","author":"S Gupta","year":"2018","unstructured":"Gupta S, Fink MK, Ghosh A, Tripathi R, Sinha PR, Sharma A, et al. Novel combination bmp7 and hgf gene therapy instigates selective myofibroblast apoptosis and reduces corneal haze in vivo. Invest Ophthalmol Vis Sci. 2018;59(2):1045\u201357.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"Suppl 1","key":"1974_CR274","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1016\/S0140-6736(15)60390-7","volume":"385","author":"W Siene Ng","year":"2015","unstructured":"Siene Ng W, Binley K, Song B, Morgan JE. Use of magnetic nanoparticles and oscillating magnetic field for non-viral gene transfer into mouse cornea. Lancet. 2015;385(Suppl 1):S75.","journal-title":"Lancet"},{"key":"1974_CR275","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","volume":"19","author":"KW Moore","year":"2001","unstructured":"Moore KW, de Waal MR, Coffman RL, O\u2019Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001;19:683\u2013765.","journal-title":"Annu Rev Immunol"},{"issue":"5","key":"1974_CR276","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1084\/jem.174.5.1209","volume":"174","author":"MR de Waal","year":"1991","unstructured":"de Waal MR, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med. 1991;174(5):1209\u201320.","journal-title":"J Exp Med"},{"issue":"4","key":"1974_CR277","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1084\/jem.174.4.915","volume":"174","author":"MR de Waal","year":"1991","unstructured":"de Waal MR, Haanen J, Spits H, Roncarolo MG, te Velde A, Figdor C, et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med. 1991;174(4):915\u201324.","journal-title":"J Exp Med"},{"issue":"3","key":"1974_CR278","doi-asserted-by":"crossref","first-page":"808","DOI":"10.4049\/jimmunol.148.3.808","volume":"148","author":"P Ralph","year":"1992","unstructured":"Ralph P, Nakoinz I, Sampson-Johannes A, Fong S, Lowe D, Min HY, et al. IL-10, T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor. J Immunol. 1992;148(3):808\u201314.","journal-title":"J Immunol"},{"issue":"6","key":"1974_CR279","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1084\/jem.178.6.2207","volume":"178","author":"MA Cassatella","year":"1993","unstructured":"Cassatella MA, Meda L, Bonora S, Ceska M, Constantin G. Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 beta in mediating the production of IL-8 triggered by lipopolysaccharide. J Exp Med. 1993;178(6):2207\u201311.","journal-title":"J Exp Med."},{"issue":"15","key":"1974_CR280","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.2217\/nnm-2018-0112","volume":"13","author":"M Vicente-Pascual","year":"2018","unstructured":"Vicente-Pascual M, Albano A, Solin\u00eds M, Serpe L, Rodr\u00edguez-Gasc\u00f3n A, Foglietta F, et al. Gene delivery in the cornea: in vitro and ex vivo evaluation of solid lipid nanoparticle-based vectors. Nanomedicine (Lond). 2018;13(15):1847\u201354.","journal-title":"Nanomedicine (Lond)"},{"issue":"6","key":"1974_CR281","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3390\/pharmaceutics12060584","volume":"12","author":"M Vicente-Pascual","year":"2020","unstructured":"Vicente-Pascual M, G\u00f3mez-Aguado I, Rodr\u00edguez-Castej\u00f3n J, Rodr\u00edguez-Gasc\u00f3n A, Muntoni E, Battaglia L, et al. Topical administration of sln-based gene therapy for the treatment of corneal inflammation by De Novo IL-10 production. Pharmaceutics. 2020;12(6):584.","journal-title":"Pharmaceutics."},{"issue":"6","key":"1974_CR282","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.preteyeres.2010.08.002","volume":"29","author":"Y Diebold","year":"2010","unstructured":"Diebold Y, Calonge M. Applications of nanoparticles in ophthalmology. Prog Retin Eye Res. 2010;29(6):596\u2013609.","journal-title":"Prog Retin Eye Res"},{"issue":"3","key":"1974_CR283","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.visres.2007.07.012","volume":"48","author":"X Cai","year":"2008","unstructured":"Cai X, Conley S, Naash M. Nanoparticle applications in ocular gene therapy. Vision Res. 2008;48(3):319\u201324.","journal-title":"Vision Res"},{"issue":"5","key":"1974_CR284","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/gt.2012.56","volume":"20","author":"L Contreras-Ruiz","year":"2013","unstructured":"Contreras-Ruiz L, Zorzi GK, Hileeto D, L\u00f3pez-Garc\u00eda A, Calonge M, Seijo B, et al. A nanomedicine to treat ocular surface inflammation: performance on an experimental dry eye murine model. Gene Ther. 2013;20(5):467\u201377.","journal-title":"Gene Ther"},{"issue":"1","key":"1974_CR285","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1186\/s12951-022-01567-7","volume":"20","author":"M Afarid","year":"2022","unstructured":"Afarid M, Mahmoodi S, Baghban R. Recent achievements in nano-based technologies for ocular disease diagnosis and treatment, review and update. J Nanobiotechnology. 2022;20(1):361.","journal-title":"J Nanobiotechnology"},{"key":"1974_CR286","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.ijbiomac.2018.10.049","volume":"121","author":"S Tiwari","year":"2019","unstructured":"Tiwari S, Bahadur P. Modified hyaluronic acid based materials for biomedical applications. Int J Biol Macromol. 2019;121:556\u201371.","journal-title":"Int J Biol Macromol"},{"key":"1974_CR287","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jphotobiol.2019.04.012","volume":"195","author":"Y Dong","year":"2019","unstructured":"Dong Y, Wan G, Yan P, Qian C, Li F, Peng G. Fabrication of resveratrol coated gold nanoparticles and investigation of their effect on diabetic retinopathy in streptozotocin induced diabetic rats. J Photochem Photobiol B. 2019;195:51\u20137.","journal-title":"J Photochem Photobiol B"},{"issue":"1","key":"1974_CR288","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/10717544.2019.1622608","volume":"26","author":"F Sun","year":"2019","unstructured":"Sun F, Zheng Z, Lan J, Li X, Li M, Song K, et al. New micelle myricetin formulation for ocular delivery: improved stability, solubility, and ocular anti-inflammatory treatment. Drug Deliv. 2019;26(1):575\u201385.","journal-title":"Drug Deliv"},{"issue":"11","key":"1974_CR289","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1080\/03639045.2017.1349787","volume":"43","author":"M Li","year":"2017","unstructured":"Li M, Xin M, Guo C, Lin G, Wu X. New nanomicelle curcumin formulation for ocular delivery: improved stability, solubility, and ocular anti-inflammatory treatment. Drug Dev Ind Pharm. 2017;43(11):1846\u201357.","journal-title":"Drug Dev Ind Pharm"},{"issue":"3","key":"1974_CR290","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.nano.2015.01.004","volume":"11","author":"HL Alvarado","year":"2015","unstructured":"Alvarado HL, Abrego G, Gardu\u00f1o-Ramirez ML, Clares B, Calpena AC, Garc\u00eda ML. Design and optimization of oleanolic\/ursolic acid-loaded nanoplatforms for ocular anti-inflammatory applications. Nanomedicine. 2015;11(3):521\u201330.","journal-title":"Nanomedicine"},{"issue":"3","key":"1974_CR291","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1076\/ceyr.19.3.234.5320","volume":"19","author":"LC Hodges","year":"1999","unstructured":"Hodges LC, Kearse CE, Green K. Intraocular pressure-lowering activity of phenolic antioxidants in normotensive rabbits. Curr Eye Res. 1999;19(3):234\u201340.","journal-title":"Curr Eye Res"},{"issue":"1","key":"1974_CR292","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.exer.2007.04.003","volume":"85","author":"A Laabich","year":"2007","unstructured":"Laabich A, Manmoto CC, Kuksa V, Leung DW, Vissvesvaran GP, Karliga I, et al. Protective effects of myricetin and related flavonols against A2E and light mediated-cell death in bovine retinal primary cell culture. Exp Eye Res. 2007;85(1):154\u201365.","journal-title":"Exp Eye Res"},{"key":"1974_CR293","first-page":"242","volume":"20","author":"R Chen","year":"2014","unstructured":"Chen R, Hollborn M, Grosche A, Reichenbach A, Wiedemann P, Bringmann A, et al. Effects of the vegetable polyphenols epigallocatechin-3-gallate, luteolin, apigenin, myricetin, quercetin, and cyanidin in primary cultures of human retinal pigment epithelial cells. Mol Vis. 2014;20:242\u201358.","journal-title":"Mol Vis"},{"key":"1974_CR294","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1515\/tnsci-2018-0020","volume":"9","author":"Q Yang","year":"2018","unstructured":"Yang Q, Li Y, Luo L. Effect of myricetin on primary open-angle glaucoma. Transl Neurosci. 2018;9:132\u201341.","journal-title":"Transl Neurosci"},{"issue":"12","key":"1974_CR295","volume":"7","author":"P Xie","year":"2012","unstructured":"Xie P, Zhang W, Yuan S, Chen Z, Yang Q, Yuan D, et al. Suppression of experimental choroidal neovascularization by curcumin in mice. PLoS ONE. 2012;7(12): e53329.","journal-title":"PLoS ONE"},{"issue":"10","key":"1974_CR296","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s00109-015-1277-z","volume":"93","author":"N Pradhan","year":"2015","unstructured":"Pradhan N, Guha R, Chowdhury S, Nandi S, Konar A, Hazra S. Curcumin nanoparticles inhibit corneal neovascularization. J Mol Med (Berl). 2015;93(10):1095\u2013106.","journal-title":"J Mol Med (Berl)"},{"issue":"23","key":"1974_CR297","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.2174\/1568026615666150619142519","volume":"15","author":"SF Nabavi","year":"2015","unstructured":"Nabavi SF, Thiagarajan R, Rastrelli L, Daglia M, Sobarzo-S\u00e1nchez E, Alinezhad H, et al. Curcumin: a natural product for diabetes and its complications. Curr Top Med Chem. 2015;15(23):2445\u201355.","journal-title":"Curr Top Med Chem"},{"issue":"7\u20138","key":"1974_CR298","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1515\/znc-2006-7-803","volume":"61","author":"MA Vasconcelos","year":"2006","unstructured":"Vasconcelos MA, Royo VA, Ferreira DS, Crotti AE, Andrade e Silva ML, Carvalho JC, et al. In vivo analgesic and anti-inflammatory activities of ursolic acid and oleanoic acid from Miconia albicans (Melastomataceae). Z Naturforsch C J Biosci. 2006;61(7\u20138):477\u201382.","journal-title":"Z Naturforsch C J Biosci."},{"issue":"2","key":"1974_CR299","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1248\/cpb.55.247","volume":"55","author":"S Ogawa","year":"2007","unstructured":"Ogawa S, Hosoi K, Ikeda N, Makino M, Fujimoto Y, Iida T. Oxyfunctionalization products of terpenoids with dimethyldioxirane and their biological activity. Chem Pharm Bull (Tokyo). 2007;55(2):247\u201350.","journal-title":"Chem Pharm Bull (Tokyo)"},{"issue":"2","key":"1974_CR300","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1089\/ars.2008.2119","volume":"11","author":"VM Berthoud","year":"2009","unstructured":"Berthoud VM, Beyer EC. Oxidative stress, lens gap junctions, and cataracts. Antioxid Redox Signal. 2009;11(2):339\u201353.","journal-title":"Antioxid Redox Signal"},{"key":"1974_CR301","first-page":"D6416","volume":"166","author":"F Cinque","year":"2022","unstructured":"Cinque F, Hoyng CB, Lechanteur YTE. Treatment of age-related macular degeneration: new insights and developments. Ned Tijdschr Geneeskd. 2022;166:D6416.","journal-title":"Ned Tijdschr Geneeskd."},{"issue":"6","key":"1974_CR302","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/nri3459","volume":"13","author":"J Ambati","year":"2013","unstructured":"Ambati J, Atkinson JP, Gelfand BD. Immunology of age-related macular degeneration. Nat Rev Immunol. 2013;13(6):438\u201351.","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"1974_CR303","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098864","volume":"9","author":"MF Roggia","year":"2014","unstructured":"Roggia MF, Imai H, Shiraya T, Noda Y, Ueta T. Protective role of glutathione peroxidase 4 in laser-induced choroidal neovascularization in mice. PLoS ONE. 2014;9(6): e98864.","journal-title":"PLoS ONE"},{"issue":"8","key":"1974_CR304","doi-asserted-by":"crossref","first-page":"4881","DOI":"10.1021\/acs.chemrev.8b00626","volume":"119","author":"B Yang","year":"2019","unstructured":"Yang B, Chen Y, Shi J. Reactive oxygen species (ROS)-based nanomedicine. Chem Rev. 2019;119(8):4881\u2013985.","journal-title":"Chem Rev"},{"issue":"5","key":"1974_CR305","doi-asserted-by":"crossref","first-page":"4669","DOI":"10.1021\/acsnano.7b00429","volume":"11","author":"RN Mitra","year":"2017","unstructured":"Mitra RN, Gao R, Zheng M, Wu MJ, Voinov MA, Smirnov AI, et al. Glycol chitosan engineered autoregenerative antioxidant significantly attenuates pathological damages in models of age-related macular degeneration. ACS Nano. 2017;11(5):4669\u201385.","journal-title":"ACS Nano"},{"key":"1974_CR306","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2020.111157","volume":"194","author":"K Song","year":"2020","unstructured":"Song K, Yan M, Li M, Geng Y, Wu X. Preparation and in vitro-in vivo evaluation of novel ocular nanomicelle formulation of thymol based on glycyrrhizin. Colloids Surf B Biointerfaces. 2020;194: 111157.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"1974_CR307","doi-asserted-by":"crossref","first-page":"15021","DOI":"10.1038\/nrdp.2015.21","volume":"1","author":"H Dimaras","year":"2015","unstructured":"Dimaras H, Corson TW, Cobrinik D, White A, Zhao J, Munier FL, et al. Retinoblastoma. Nat Rev Dis Primers. 2015;1:15021.","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"1974_CR308","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0161-6420(93)31667-2","volume":"100","author":"CL Shields","year":"1993","unstructured":"Shields CL, Shields JA, De Potter P, Minelli S, Hernandez C, Brady LW, et al. Plaque radiotherapy in the management of retinoblastoma. Use as a primary and secondary treatment. Ophthalmology. 1993;100(2):216\u201324.","journal-title":"Ophthalmology."},{"key":"1974_CR309","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejpb.2015.03.018","volume":"93","author":"E P\u00e9rez-Herrero","year":"2015","unstructured":"P\u00e9rez-Herrero E, Fern\u00e1ndez-Medarde A. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy. Eur J Pharm Biopharm. 2015;93:52\u201379.","journal-title":"Eur J Pharm Biopharm"},{"issue":"7","key":"1974_CR310","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.ctrv.2008.04.003","volume":"34","author":"LS Jabr-Milane","year":"2008","unstructured":"Jabr-Milane LS, van Vlerken LE, Yadav S, Amiji MM. Multi-functional nanocarriers to overcome tumor drug resistance. Cancer Treat Rev. 2008;34(7):592\u2013602.","journal-title":"Cancer Treat Rev"},{"issue":"4","key":"1974_CR311","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.bbrc.2005.07.030","volume":"334","author":"SA Ciafr\u00e8","year":"2005","unstructured":"Ciafr\u00e8 SA, Galardi S, Mangiola A, Ferracin M, Liu CG, Sabatino G, et al. Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun. 2005;334(4):1351\u20138.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"1974_CR312","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.bbrc.2010.12.055","volume":"404","author":"KH Shin","year":"2011","unstructured":"Shin KH, Bae SD, Hong HS, Kim RH, Kang MK, Park NH. miR-181a shows tumor suppressive effect against oral squamous cell carcinoma cells by downregulating K-ras. Biochem Biophys Res Commun. 2011;404(4):896\u2013902.","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"1974_CR313","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/aps.2013.35","volume":"34","author":"H Li","year":"2013","unstructured":"Li H, Yang BB. Friend or foe: the role of microRNA in chemotherapy resistance. Acta Pharmacol Sin. 2013;34(7):870\u20139.","journal-title":"Acta Pharmacol Sin"},{"key":"1974_CR314","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jconrel.2014.09.001","volume":"194","author":"NS Gandhi","year":"2014","unstructured":"Gandhi NS, Tekade RK, Chougule MB. Nanocarrier mediated delivery of siRNA\/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances. J Control Release. 2014;194:238\u201356.","journal-title":"J Control Release"},{"key":"1974_CR315","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.omtn.2017.07.001","volume":"8","author":"HL Moody","year":"2017","unstructured":"Moody HL, Lind MJ, Maher SG. MicroRNA-31 regulates chemosensitivity in malignant pleural mesothelioma. Mol Ther Nucleic Acids. 2017;8:317\u201329.","journal-title":"Mol Ther Nucleic Acids"},{"key":"1974_CR316","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jconrel.2019.02.014","volume":"298","author":"SN Tabatabaei","year":"2019","unstructured":"Tabatabaei SN, Derbali RM, Yang C, Superstein R, Hamel P, Chain JL, et al. Co-delivery of miR-181a and melphalan by lipid nanoparticles for treatment of seeded retinoblastoma. J Control Release. 2019;298:177\u201385.","journal-title":"J Control Release"},{"key":"1974_CR317","doi-asserted-by":"crossref","first-page":"102259","DOI":"10.1016\/j.jddst.2020.102259","volume":"61","author":"R Godse","year":"2021","unstructured":"Godse R, Rathod M, De A, Shinde U. Intravitreal galactose conjugated polymeric nanoparticles of etoposide for retinoblastoma. J Drug Deliv Sci and Technol. 2021;61:102259.","journal-title":"J Drug Deliv Sci and Technol."},{"key":"1974_CR318","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121320","volume":"280","author":"Q Tang","year":"2022","unstructured":"Tang Q, Lu B, He J, Chen X, Fu Q, Han H, et al. Exosomes-loaded thermosensitive hydrogels for corneal epithelium and stroma regeneration. Biomaterials. 2022;280: 121320.","journal-title":"Biomaterials"},{"key":"1974_CR319","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.actbio.2017.08.001","volume":"61","author":"Q Tang","year":"2017","unstructured":"Tang Q, Luo C, Lu B, Fu Q, Yin H, Qin Z, et al. Thermosensitive chitosan-based hydrogels releasing stromal cell derived factor-1 alpha recruit MSC for corneal epithelium regeneration. Acta Biomater. 2017;61:101\u201313.","journal-title":"Acta Biomater"},{"issue":"1","key":"1974_CR320","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/WCO.0000000000000284","volume":"29","author":"F Behar-Cohen","year":"2016","unstructured":"Behar-Cohen F, Zhao M. Corticosteroids and the retina: a role for the mineralocorticoid receptor. Curr Opin Neurol. 2016;29(1):49\u201354.","journal-title":"Curr Opin Neurol"},{"issue":"9","key":"1974_CR321","doi-asserted-by":"crossref","first-page":"6340","DOI":"10.1167\/iovs.11-7675","volume":"52","author":"M Zhao","year":"2011","unstructured":"Zhao M, Bousquet E, Valamanesh F, Farman N, Jeanny JC, Jaisser F, et al. Differential regulations of AQP4 and Kir4.1 by triamcinolone acetonide and dexamethasone in the healthy and inflamed retina. Invest Ophthalmol Vis Sci. 2011;52(9):6340\u20137.","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"1974_CR322","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.steroids.2017.11.002","volume":"133","author":"RS Sulaiman","year":"2018","unstructured":"Sulaiman RS, Kadmiel M, Cidlowski JA. Glucocorticoid receptor signaling in the eye. Steroids. 2018;133:60\u20136.","journal-title":"Steroids"},{"key":"1974_CR323","doi-asserted-by":"crossref","first-page":"109787","DOI":"10.1016\/j.msec.2019.109787","volume":"103","author":"EY Shin","year":"2019","unstructured":"Shin EY, Park JH, Shin ME, Song JE, Thangavelu M, Carlomagno C, et al. Injectable taurine-loaded alginate hydrogels for retinal pigment epithelium (RPE) regeneration. Mater Sci Eng C Mater Biol Appl. 2019;103:109787.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"1974_CR324","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ijbiomac.2018.05.127","volume":"117","author":"JH Park","year":"2018","unstructured":"Park JH, Shin EY, Shin ME, Choi MJ, Carlomagno C, Song JE, et al. Enhanced retinal pigment epithelium (RPE) regeneration using curcumin\/alginate hydrogels: In vitro evaluation. Int J Biol Macromol. 2018;117:546\u201352.","journal-title":"Int J Biol Macromol"},{"issue":"6","key":"1974_CR325","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.3390\/polym12061397","volume":"12","author":"SS Das","year":"2020","unstructured":"Das SS, Bharadwaj P, Bilal M, Barani M, Rahdar A, Taboada P, et al. Stimuli-responsive polymeric nanocarriers for drug delivery, imaging, and theragnosis. Polymers (Basel). 2020;12(6):1397.","journal-title":"Polymers (Basel)."},{"issue":"1","key":"1974_CR326","doi-asserted-by":"crossref","first-page":"5945","DOI":"10.1038\/s41598-019-42324-5","volume":"9","author":"VP Nguyen","year":"2019","unstructured":"Nguyen VP, Li Y, Qian W, Liu B, Tian C, Zhang W, et al. Contrast agent enhanced multimodal photoacoustic microscopy and optical coherence tomography for imaging of rabbit choroidal and retinal vessels in vivo. Sci Rep. 2019;9(1):5945.","journal-title":"Sci Rep"},{"issue":"1","key":"1974_CR327","doi-asserted-by":"crossref","first-page":"9228","DOI":"10.1038\/s41598-017-10050-5","volume":"7","author":"M Lapierre-Landry","year":"2017","unstructured":"Lapierre-Landry M, Gordon AY, Penn JS, Skala MC. In vivo photothermal optical coherence tomography of endogenous and exogenous contrast agents in the eye. Sci Rep. 2017;7(1):9228.","journal-title":"Sci Rep"},{"issue":"6","key":"1974_CR328","first-page":"66002","volume":"21","author":"D Sen","year":"2016","unstructured":"Sen D, SoRelle ED, Liba O, Dalal R, Paulus YM, Kim TW, et al. High-resolution contrast-enhanced optical coherence tomography in mice retinae. J Biomed Opt. 2016;21(6):66002.","journal-title":"J Biomed Opt"},{"issue":"10","key":"1974_CR329","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.3390\/nano10102028","volume":"10","author":"LM Shaker","year":"2020","unstructured":"Shaker LM, Al-Amiery AA, Kadhum AAH, Takriff MS. Manufacture of Contact Lens of Nanoparticle-Doped Polymer Complemented with ZEMAX. Nanomaterials (Basel). 2020;10(10):2028.","journal-title":"Nanomaterials (Basel)."},{"issue":"7","key":"1974_CR330","doi-asserted-by":"crossref","first-page":"836","DOI":"10.3109\/17435390.2016.1153165","volume":"10","author":"NK Mehra","year":"2016","unstructured":"Mehra NK, Cai D, Kuo L, Hein T, Palakurthi S. Safety and toxicity of nanomaterials for ocular drug delivery applications. Nanotoxicology. 2016;10(7):836\u201360.","journal-title":"Nanotoxicology"},{"issue":"10","key":"1974_CR331","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1167\/tvst.10.10.6","volume":"10","author":"S Gupta","year":"2021","unstructured":"Gupta S, Sinha NR, Martin LM, Keele LM, Sinha PR, Rodier JT, et al. Long-term safety and tolerability of bmp7 and hgf gene overexpression in rabbit cornea. Transl Vis Sci Technol. 2021;10(10):6.","journal-title":"Transl Vis Sci Technol"},{"issue":"2","key":"1974_CR332","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ajo.2010.03.019","volume":"150","author":"MA Zarbin","year":"2010","unstructured":"Zarbin MA, Montemagno C, Leary JF, Ritch R. Nanomedicine in ophthalmology: the new frontier. Am J Ophthalmol. 2010;150(2):144-162.e2.","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"1974_CR333","doi-asserted-by":"crossref","first-page":"857","DOI":"10.2174\/138920021131400107","volume":"14","author":"X Li","year":"2013","unstructured":"Li X, Li L, Zhang Z, Chen H. An overview on pharmacokinetics, disposition, and safety of nanoparticles in ocular applications. Curr Drug Metab. 2013;14(8):857\u201362.","journal-title":"Curr Drug Metab"},{"key":"1974_CR334","doi-asserted-by":"crossref","first-page":"6497","DOI":"10.2147\/IJN.S329831","volume":"16","author":"J Zhang","year":"2021","unstructured":"Zhang J, Jiao J, Niu M, Gao X, Zhang G, Yu H, et al. Ten years of knowledge of nano-carrier based drug delivery systems in ophthalmology: current evidence, challenges, and future prospective. Int J Nanomedicine. 2021;16:6497\u2013530.","journal-title":"Int J Nanomedicine"},{"key":"1974_CR335","doi-asserted-by":"crossref","DOI":"10.1016\/j.envpol.2020.114297","volume":"262","author":"K Kik","year":"2020","unstructured":"Kik K, Bukowska B, Sici\u0144ska P. Polystyrene nanoparticles: Sources, occurrence in the environment, distribution in tissues, accumulation and toxicity to various organisms. Environ Pollut. 2020;262: 114297.","journal-title":"Environ Pollut"},{"issue":"2","key":"1974_CR336","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3390\/nano10020271","volume":"10","author":"G Vales","year":"2020","unstructured":"Vales G, Suhonen S, Siivola KM, Savolainen KM, Catal\u00e1n J, Norppa H. Size, Surface Functionalization, and Genotoxicity of Gold Nanoparticles In Vitro. Nanomaterials (Basel). 2020;10(2):271.","journal-title":"Nanomaterials (Basel)."},{"issue":"5","key":"1974_CR337","doi-asserted-by":"crossref","first-page":"5536","DOI":"10.1021\/acsnano.6b02086","volume":"10","author":"SG Elci","year":"2016","unstructured":"Elci SG, Jiang Y, Yan B, Kim ST, Saha K, Moyano DF, et al. Surface charge controls the suborgan biodistributions of gold nanoparticles. ACS Nano. 2016;10(5):5536\u201342.","journal-title":"ACS Nano"},{"issue":"8","key":"1974_CR338","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1080\/17435390.2018.1480813","volume":"12","author":"W Wu","year":"2018","unstructured":"Wu W, Yan L, Chen S, Li Q, Gu Z, Xu H, et al. Investigating oxidation state-induced toxicity of PEGylated graphene oxide in ocular tissue using gene expression profiles. Nanotoxicology. 2018;12(8):819\u201335.","journal-title":"Nanotoxicology"},{"issue":"5","key":"1974_CR339","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.vaccine.2019.11.031","volume":"38","author":"X Yan","year":"2020","unstructured":"Yan X, Zhou M, Yu S, Jin Z, Zhao K. An overview of biodegradable nanomaterials and applications in vaccines. Vaccine. 2020;38(5):1096\u2013104.","journal-title":"Vaccine"},{"key":"1974_CR340","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jconrel.2020.04.052","volume":"324","author":"Y Wang","year":"2020","unstructured":"Wang Y, Shahi PK, Xie R, Zhang H, Abdeen AA, Yodsanit N, et al. A pH-responsive silica-metal-organic framework hybrid nanoparticle for the delivery of hydrophilic drugs, nucleic acids, and CRISPR-Cas9 genome-editing machineries. J Control Release. 2020;324:194\u2013203.","journal-title":"J Control Release"},{"key":"1974_CR341","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.tox.2014.11.003","volume":"327","author":"SL Wilson","year":"2015","unstructured":"Wilson SL, Ahearne M, Hopkinson A. An overview of current techniques for ocular toxicity testing. Toxicology. 2015;327:32\u201346.","journal-title":"Toxicology"},{"issue":"7","key":"1974_CR342","doi-asserted-by":"crossref","first-page":"980","DOI":"10.3390\/biom10070980","volume":"10","author":"I Baldim","year":"2020","unstructured":"Baldim I, Oliveira WP, Kadian V, Rao R, Yadav N, Mahant S, et al. Natural ergot alkaloids in ocular pharmacotherapy: known molecules for novel nanoparticle-based delivery systems. Biomolecules. 2020;10(7):980.","journal-title":"Biomolecules."},{"issue":"46","key":"1974_CR343","doi-asserted-by":"crossref","first-page":"27835","DOI":"10.1039\/D0RA04971A","volume":"10","author":"S Gorantla","year":"2020","unstructured":"Gorantla S, Rapalli VK, Waghule T, Singh PP, Dubey SK, Saha RN, et al. Nanocarriers for ocular drug delivery: current status and translational opportunity. RSC Adv. 2020;10(46):27835\u201355.","journal-title":"RSC Adv"},{"issue":"15","key":"1974_CR344","volume":"9","author":"Z Tang","year":"2022","unstructured":"Tang Z, Fan X, Chen Y, Gu P. Ocular Nanomedicine. Adv Sci (Weinh). 2022;9(15): e2003699.","journal-title":"Adv Sci (Weinh)"},{"issue":"5","key":"1974_CR345","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1167\/iovs.18-26251","volume":"60","author":"LB Sims","year":"2019","unstructured":"Sims LB, Tyo KM, Stocke S, Mahmoud MY, Ramasubramanian A, Steinbach-Rankins JM. Surface-modified melphalan nanoparticles for intravitreal chemotherapy of retinoblastoma. Invest Ophthalmol Vis Sci. 2019;60(5):1696\u2013705.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7594","key":"1974_CR346","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nature17181","volume":"531","author":"H Lin","year":"2016","unstructured":"Lin H, Ouyang H, Zhu J, Huang S, Liu Z, Chen S, et al. Lens regeneration using endogenous stem cells with gain of visual function. Nature. 2016;531(7594):323\u20138.","journal-title":"Nature"},{"issue":"16","key":"1974_CR347","doi-asserted-by":"crossref","first-page":"1802289","DOI":"10.1002\/advs.201802289","volume":"6","author":"S Zhu","year":"2019","unstructured":"Zhu S, Gong L, Li Y, Xu H, Gu Z, Zhao Y. Safety assessment of nanomaterials to eyes: an important but neglected issue. Adv Sci (Weinh). 2019;6(16):1802289.","journal-title":"Adv Sci (Weinh)"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-023-01974-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-023-01974-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-023-01974-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T12:06:33Z","timestamp":1729944393000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-023-01974-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,19]]},"references-count":347,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1974"],"URL":"https:\/\/doi.org\/10.1186\/s12951-023-01974-4","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,19]]},"assertion":[{"value":"11 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"282"}}